0001307954 false --12-31 Q1 2025 9 8 271 233 0.01 0.01 1,200,000,000 1,200,000,000 263,202,496 262,751,907 172,595,368 172,144,779 90,607,128 90,607,128 0.25 0.25 9 8 271 233 2,728 2,728 2,728 2,728 3 0 9 120 http://fasb.org/us-gaap/2025#AccountsPayableCurrent 1.475 http://fasb.org/us-gaap/2025#SecuredOvernightFinancingRateSofrMember http://fasb.org/us-gaap/2025#SecuredOvernightFinancingRateSofrMember 750 743 400 398 350 345 January 31, 2027 0.95 July 31, 2027 1.45 108 59 1 306 315 0 0.25 61 56 67 85 43 91 5 15 6 9 6 3 3 0 0 0 0 0 0 0 3 3 3 http://fasb.org/us-gaap/2025#OtherNonoperatingIncomeExpense http://fasb.org/us-gaap/2025#OtherNonoperatingIncomeExpense http://fasb.org/us-gaap/2025#OtherNonoperatingIncomeExpense http://fasb.org/us-gaap/2025#OtherNonoperatingIncomeExpense As of March 31, 2025, a total of 175,238 restricted stock units were vested but not yet issued, of which 38,868 vested during the three months ended March 31, 2025. These shares have not been reflected as vested shares in this table because, in accordance with the restricted stock unit agreements, shares of common stock are not issued for vested restricted stock units until termination of employment. Amounts are net of tax of $67 million as of both March 31, 2024 and January 1, 2024. The applicable rate for our U.S. A/R Program is defined by the lender as Term SOFR. The applicable rate for our EU A/R Program is either Term SOFR, EURIBOR or SONIA (Sterling Overnight Interbank Average Rate). Details of amounts reclassified from accumulated other comprehensive loss relate only to pension and other postretirement benefits. See table below for details about these reclassifications. At March 31, 2025 and December 31, 2024, respectively, $15 and $6 of cash and cash equivalents, $20 and $19 of accounts and notes receivable (net), $63 and $57 of inventories, $124 each of property, plant and equipment (net), $36 and $37 of other noncurrent assets, $108 and $111 of accounts payable, $17 and $21 of accrued liabilities, $9 each of current portion of debt, $9 and $6 of current operating lease liabilities, $5 and $7 of long-term debt, $13 and $15 of noncurrent operating lease liabilities and $16 each of other noncurrent liabilities from consolidated variable interest entities are included in the respective balance sheet captions above. See “Note 6. Variable Interest Entities.” These assets can only be used to settle obligations of the variable interest entities, and creditors of these liabilities do not have recourse to our general credit. Other segment items include other operating and non-operating income and expense items and foreign currency exchange effects, less certain of the adjustments noted in footnote (5) below. These accumulated other comprehensive loss components are included in the computation of net periodic pension costs. See “Note 13. Employee Benefit Plans.” Amounts are net of tax of $61 million as of both March 31, 2025 and January 1, 2025. Amounts are net of tax of $43 million as of both March 31, 2024 and January 1, 2024. Adjusted fixed costs primarily include personnel and maintenance costs at our manufacturing facilities, selling, general and administrative expenses and research and development expenses, less depreciation and amortization and certain of the adjustments noted in footnote (5) below. The amount of actual availability under our A/R Programs may be lower based on the level of eligible receivables sold, changes in the credit ratings of our customers, customer concentration levels and certain characteristics of the accounts receivable being transferred, as defined in the applicable agreements. Geographic information for revenues is based upon countries into which product is sold. Amounts are net of tax of $57 million and $60 million as of March 31, 2025 and January 1, 2025, respectively. We use segment adjusted EBITDA as the measure of each segment’s profit or loss. We believe that segment adjusted EBITDA more accurately reflects what our chief operating decision maker, who has been determined to be our Chief Executive Officer, uses to make decisions about resources to be allocated to the segments and assess their financial performance. Segment adjusted EBITDA is defined as net income of Huntsman Corporation or Huntsman International, as appropriate, before interest, income tax, depreciation and amortization, net income attributable to noncontrolling interests and certain Corporate and other items, as well as eliminating the following adjustments: (a) business acquisition and integration gain (expenses) and purchase accounting inventory adjustments, net; (b) certain legal and other settlements and related income (expenses); (c) amortization of pension and postretirement actuarial losses; (d) restructuring, impairment, plant closing and transition costs; and (e) loss from discontinued operations, net of tax Amounts are net of tax of $56 million as of both March 31, 2024 and January 1, 2024. Pension and other postretirement benefits amounts in parentheses indicate credits on our condensed consolidated statements of operations. Amounts are net of tax of $44 million and $47 million as of March 31, 2025 and January 1, 2025, respectively. On March 31, 2025, we had an additional $3 million (U.S. dollar equivalent) of letters of credit and bank guarantees issued and outstanding under our 2022 Revolving Credit Facility. Includes costs associated with transition activities relating primarily to our program to realign our cost structure in Europe and our Corporate program to optimize our global approach to managed services in various information technology functions. A reconciliation of total reportable segments’ revenues to total consolidated revenues is provided in “Note 12. Revenue Recognition.” Corporate and other costs, net includes unallocated corporate overhead, unallocated foreign exchange gains and losses, LIFO inventory valuation reserve adjustments, nonoperating income and expense and gains and losses on the disposition of corporate assets. Amounts are net of tax of $85 million as of both March 31, 2025 and January 1, 2025, respectively. As of March 31, 2025, we had approximately $5 million (U.S. dollar equivalent) of letters of credit issued and outstanding under our U.S. A/R Program. Variable direct costs primarily include raw materials, utilities and freight-related costs. A total of 186,825 performance share unit awards are reflected in the vested shares in this table, which represents the target number of performance share unit awards for this grant and were included in the balance at December 31, 2024. Due to the target performance criteria not being met, only 123,119 performance share unit awards with a grant date fair value of $60.36 were issued during the three months ended March 31, 2025. Interest rates on borrowings under the 2022 Revolving Credit Facility vary based on the type of loan and Huntsman International’s debt ratings. The representative interest rate for U.S. dollar borrowings as of March 31, 2025 was 1.475% above Term SOFR. Amounts are presented in other income, net. Amounts are net of tax of $91 million as of both March 31, 2024 and January 1, 2024. These accumulated other comprehensive loss components are included in the computation of net periodic pension costs. See “Note 12. Employee Benefit Plans.” 15 6 20 19 63 57 124 124 36 37 108 111 17 21 9 9 9 6 5 7 13 15 16 16 15 6 20 19 63 57 124 124 36 37 108 111 17 21 9 9 9 6 5 7 13 15 16 16 20 21 20 21 00013079542025-01-012025-03-31 xbrli:shares 00013079542025-04-23 iso4217:USD 00013079542025-03-31 00013079542024-12-31 0001307954us-gaap:AssetPledgedAsCollateralMember2025-03-31 0001307954us-gaap:AssetPledgedAsCollateralMember2024-12-31 0001307954us-gaap:RelatedPartyMember2025-03-31 0001307954us-gaap:RelatedPartyMember2024-12-31 0001307954us-gaap:NonrelatedPartyMember2025-03-31 0001307954us-gaap:NonrelatedPartyMember2024-12-31 iso4217:USDxbrli:shares 0001307954hun:ThirdPartyCustomersMember2025-01-012025-03-31 0001307954hun:ThirdPartyCustomersMember2024-01-012024-03-31 0001307954hun:RelatedPartyCustomersMember2025-01-012025-03-31 0001307954hun:RelatedPartyCustomersMember2024-01-012024-03-31 00013079542024-01-012024-03-31 0001307954hun:CommonStockOutstandingMember2024-12-31 0001307954us-gaap:CommonStockMember2024-12-31 0001307954us-gaap:AdditionalPaidInCapitalMember2024-12-31 0001307954us-gaap:TreasuryStockCommonMember2024-12-31 0001307954us-gaap:DeferredCompensationShareBasedPaymentsMember2024-12-31 0001307954us-gaap:RetainedEarningsMember2024-12-31 0001307954us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-31 0001307954us-gaap:NoncontrollingInterestMember2024-12-31 0001307954us-gaap:CommonStockMember2025-01-012025-03-31 0001307954us-gaap:AdditionalPaidInCapitalMember2025-01-012025-03-31 0001307954us-gaap:TreasuryStockCommonMember2025-01-012025-03-31 0001307954us-gaap:DeferredCompensationShareBasedPaymentsMember2025-01-012025-03-31 0001307954us-gaap:RetainedEarningsMember2025-01-012025-03-31 0001307954us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-01-012025-03-31 0001307954us-gaap:NoncontrollingInterestMember2025-01-012025-03-31 0001307954hun:CommonStockOutstandingMember2025-01-012025-03-31 0001307954hun:CommonStockOutstandingMember2025-03-31 0001307954us-gaap:CommonStockMember2025-03-31 0001307954us-gaap:AdditionalPaidInCapitalMember2025-03-31 0001307954us-gaap:TreasuryStockCommonMember2025-03-31 0001307954us-gaap:DeferredCompensationShareBasedPaymentsMember2025-03-31 0001307954us-gaap:RetainedEarningsMember2025-03-31 0001307954us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-03-31 0001307954us-gaap:NoncontrollingInterestMember2025-03-31 0001307954hun:CommonStockOutstandingMember2023-12-31 0001307954us-gaap:CommonStockMember2023-12-31 0001307954us-gaap:AdditionalPaidInCapitalMember2023-12-31 0001307954us-gaap:TreasuryStockCommonMember2023-12-31 0001307954us-gaap:DeferredCompensationShareBasedPaymentsMember2023-12-31 0001307954us-gaap:RetainedEarningsMember2023-12-31 0001307954us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-31 0001307954us-gaap:NoncontrollingInterestMember2023-12-31 00013079542023-12-31 0001307954us-gaap:CommonStockMember2024-01-012024-03-31 0001307954us-gaap:AdditionalPaidInCapitalMember2024-01-012024-03-31 0001307954us-gaap:TreasuryStockCommonMember2024-01-012024-03-31 0001307954us-gaap:DeferredCompensationShareBasedPaymentsMember2024-01-012024-03-31 0001307954us-gaap:RetainedEarningsMember2024-01-012024-03-31 0001307954us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-31 0001307954us-gaap:NoncontrollingInterestMember2024-01-012024-03-31 0001307954hun:CommonStockOutstandingMember2024-01-012024-03-31 0001307954hun:CommonStockOutstandingMember2024-03-31 0001307954us-gaap:CommonStockMember2024-03-31 0001307954us-gaap:AdditionalPaidInCapitalMember2024-03-31 0001307954us-gaap:TreasuryStockCommonMember2024-03-31 0001307954us-gaap:DeferredCompensationShareBasedPaymentsMember2024-03-31 0001307954us-gaap:RetainedEarningsMember2024-03-31 0001307954us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-31 0001307954us-gaap:NoncontrollingInterestMember2024-03-31 00013079542024-03-31 0001307954hun:HuntsmanInternationalLLCMember2025-03-31 0001307954hun:HuntsmanInternationalLLCMember2024-12-31 0001307954hun:HuntsmanInternationalLLCMemberus-gaap:AssetPledgedAsCollateralMember2025-03-31 0001307954hun:HuntsmanInternationalLLCMemberus-gaap:AssetPledgedAsCollateralMember2024-12-31 0001307954hun:HuntsmanInternationalLLCMemberus-gaap:RelatedPartyMember2025-03-31 0001307954hun:HuntsmanInternationalLLCMemberus-gaap:RelatedPartyMember2024-12-31 0001307954hun:HuntsmanInternationalLLCMemberus-gaap:NonrelatedPartyMember2025-03-31 0001307954hun:HuntsmanInternationalLLCMemberus-gaap:NonrelatedPartyMember2024-12-31 0001307954hun:HuntsmanInternationalLLCMemberhun:ThirdPartyCustomersMember2025-01-012025-03-31 0001307954hun:HuntsmanInternationalLLCMemberhun:ThirdPartyCustomersMember2024-01-012024-03-31 0001307954hun:HuntsmanInternationalLLCMemberhun:RelatedPartyCustomersMember2025-01-012025-03-31 0001307954hun:HuntsmanInternationalLLCMemberhun:RelatedPartyCustomersMember2024-01-012024-03-31 0001307954hun:HuntsmanInternationalLLCMember2025-01-012025-03-31 0001307954hun:HuntsmanInternationalLLCMember2024-01-012024-03-31 0001307954hun:HuntsmanInternationalLLCMemberus-gaap:MemberUnitsMember2024-12-31 0001307954hun:HuntsmanInternationalLLCMemberus-gaap:RetainedEarningsMember2024-12-31 0001307954hun:HuntsmanInternationalLLCMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-31 0001307954hun:HuntsmanInternationalLLCMemberus-gaap:NoncontrollingInterestMember2024-12-31 0001307954hun:HuntsmanInternationalLLCMemberus-gaap:MemberUnitsMember2025-01-012025-03-31 0001307954hun:HuntsmanInternationalLLCMemberus-gaap:RetainedEarningsMember2025-01-012025-03-31 0001307954hun:HuntsmanInternationalLLCMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2025-01-012025-03-31 0001307954hun:HuntsmanInternationalLLCMemberus-gaap:NoncontrollingInterestMember2025-01-012025-03-31 0001307954hun:HuntsmanInternationalLLCMemberus-gaap:MemberUnitsMember2025-03-31 0001307954hun:HuntsmanInternationalLLCMemberus-gaap:RetainedEarningsMember2025-03-31 0001307954hun:HuntsmanInternationalLLCMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2025-03-31 0001307954hun:HuntsmanInternationalLLCMemberus-gaap:NoncontrollingInterestMember2025-03-31 0001307954hun:HuntsmanInternationalLLCMemberus-gaap:MemberUnitsMember2023-12-31 0001307954hun:HuntsmanInternationalLLCMemberus-gaap:RetainedEarningsMember2023-12-31 0001307954hun:HuntsmanInternationalLLCMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-31 0001307954hun:HuntsmanInternationalLLCMemberus-gaap:NoncontrollingInterestMember2023-12-31 0001307954hun:HuntsmanInternationalLLCMember2023-12-31 0001307954hun:HuntsmanInternationalLLCMemberus-gaap:MemberUnitsMember2024-01-012024-03-31 0001307954hun:HuntsmanInternationalLLCMemberus-gaap:RetainedEarningsMember2024-01-012024-03-31 0001307954hun:HuntsmanInternationalLLCMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-31 0001307954hun:HuntsmanInternationalLLCMemberus-gaap:NoncontrollingInterestMember2024-01-012024-03-31 0001307954hun:HuntsmanInternationalLLCMemberus-gaap:MemberUnitsMember2024-03-31 0001307954hun:HuntsmanInternationalLLCMemberus-gaap:RetainedEarningsMember2024-03-31 0001307954hun:HuntsmanInternationalLLCMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-31 0001307954hun:HuntsmanInternationalLLCMemberus-gaap:NoncontrollingInterestMember2024-03-31 0001307954hun:HuntsmanInternationalLLCMember2024-03-31 xbrli:pure 0001307954hun:ShanghaiLianhengIsocyanateCompanyLtdSlicMember2024-01-312024-01-31 0001307954hun:ShanghaiLianhengIsocyanateCompanyLtdSlicMember2024-07-012024-09-30 0001307954hun:ShanghaiLianhengIsocyanateCompanyLtdSlicMember2025-01-012025-03-31 0001307954hun:ShanghaiLianhengIsocyanateCompanyLtdSlicMember2024-01-012024-12-31 0001307954hun:ShanghaiLianhengIsocyanateCompanyLtdSlicMember2024-01-31 0001307954us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMemberhun:TextileEffectsMember2024-03-31 0001307954us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMemberhun:TextileEffectsMember2025-01-012025-03-31 0001307954us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMemberhun:TextileEffectsMember2024-01-012024-03-31 0001307954hun:RubiconLlcMember2025-01-012025-03-31 0001307954hun:ArabianAminesCompanyMember2025-01-012025-03-31 0001307954us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2025-03-31 0001307954us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2024-12-31 0001307954us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2025-01-012025-03-31 0001307954us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2024-01-012024-03-31 utr:D 0001307954srt:MinimumMember2025-03-31 0001307954srt:MaximumMember2025-03-31 thunderdome:item 0001307954us-gaap:EmployeeSeveranceMember2024-12-31 0001307954us-gaap:EmployeeSeveranceMember2025-01-012025-03-31 0001307954us-gaap:EmployeeSeveranceMember2025-03-31 0001307954us-gaap:OperatingSegmentsMemberhun:PolyurethanesMember2024-12-31 0001307954us-gaap:OperatingSegmentsMemberhun:PerformanceProductsMember2024-12-31 0001307954us-gaap:OperatingSegmentsMemberhun:AdvancedMaterialsMember2024-12-31 0001307954hun:CorporateAndReconcilingItemsMember2024-12-31 0001307954us-gaap:OperatingSegmentsMemberhun:PolyurethanesMember2025-01-012025-03-31 0001307954us-gaap:OperatingSegmentsMemberhun:PerformanceProductsMember2025-01-012025-03-31 0001307954us-gaap:OperatingSegmentsMemberhun:AdvancedMaterialsMember2025-01-012025-03-31 0001307954hun:CorporateAndReconcilingItemsMember2025-01-012025-03-31 0001307954us-gaap:OperatingSegmentsMemberhun:PolyurethanesMember2025-03-31 0001307954us-gaap:OperatingSegmentsMemberhun:PerformanceProductsMember2025-03-31 0001307954us-gaap:OperatingSegmentsMemberhun:AdvancedMaterialsMember2025-03-31 0001307954hun:CorporateAndReconcilingItemsMember2025-03-31 0001307954us-gaap:EmployeeSeveranceMemberhun:RestructuringProgramsToOptimizeManagedServicesAndAlignAndOptimizeProcessesAndSystemsMember2025-01-012025-03-31 0001307954us-gaap:EmployeeSeveranceMemberhun:RestructuringProgramsToOptimizeManagedServicesAndAlignAndOptimizeProcessesAndSystemsMember2025-03-31 0001307954hun:EmployeeSeveranceAndAcceleratedDepreciationMemberhun:RestructuringProgramToOptimizeTheSegmentsManufacturingProcessesAndCostStructureMemberhun:AdvancedMaterialsMember2025-01-012025-03-31 0001307954hun:EmployeeSeveranceAndAcceleratedDepreciationMemberhun:RestructuringProgramToOptimizeTheSegmentsManufacturingProcessesAndCostStructureMemberhun:AdvancedMaterialsMember2024-01-012024-03-31 0001307954hun:EmployeeSeveranceAndAcceleratedDepreciationMemberhun:RestructuringProgramToOptimizeTheSegmentsManufacturingProcessesAndCostStructureMemberhun:AdvancedMaterialsMember2025-03-31 0001307954us-gaap:EmployeeSeveranceMemberhun:RestructuringProgramsToOptimizeManagedServicesAndAlignAndOptimizeProcessesAndSystemsMember2024-01-012024-03-31 0001307954hun:TheRevolvingCreditFacilityMember2025-03-31 0001307954hun:TheRevolvingCreditFacilityMember2024-12-31 0001307954hun:TheSeniorNotesMember2025-03-31 0001307954hun:TheSeniorNotesMember2024-12-31 0001307954hun:AccountsReceivableProgramsMember2025-03-31 0001307954hun:AccountsReceivableProgramsMember2024-12-31 0001307954hun:VariableInterestEntitiesDebtMember2025-03-31 0001307954hun:VariableInterestEntitiesDebtMember2024-12-31 0001307954hun:OtherDebtInstrumentsMember2025-03-31 0001307954hun:OtherDebtInstrumentsMember2024-12-31 0001307954hun:TheRevolvingCreditFacilityMemberhun:HuntsmanInternationalLLCMember2022-05-20 0001307954hun:TheRevolvingCreditFacilityMemberhun:HuntsmanInternationalLLCMember2022-05-202022-05-20 0001307954hun:TheRevolvingCreditFacilityMemberhun:HuntsmanInternationalLLCMember2025-03-31 0001307954hun:TheRevolvingCreditFacilityMemberhun:HuntsmanInternationalLLCMember2025-01-012025-03-31 0001307954hun:SeniorNotesMaturingApril2025Memberhun:HuntsmanInternationalLLCMember2025-03-28 0001307954hun:SeniorNotesMaturingApril2025Memberhun:HuntsmanInternationalLLCMember2025-03-282025-03-28 0001307954hun:SeniorNotesMaturingMay2029Memberhun:HuntsmanInternationalLLCMember2025-03-31 0001307954hun:SeniorNotesMaturingJune2031Memberhun:HuntsmanInternationalLLCMember2025-03-31 0001307954hun:SeniorNoteMaturingInOctober2034Memberhun:HuntsmanInternationalLLCMember2025-03-31 0001307954hun:USARProgramMember2025-01-012025-03-31 0001307954hun:USARProgramMember2025-03-31 0001307954hun:USARProgramMemberhun:TermSecuredOvernightFinancingRateTermSOFRMember2025-01-012025-03-31 0001307954hun:EUARProgramMember2025-01-012025-03-31 iso4217:EUR 0001307954hun:EUARProgramMember2025-03-31 0001307954hun:EUARProgramMemberhun:TermSofrEuriborOrSoniaMember2025-01-012025-03-31 0001307954hun:AccountsReceivableProgramsMemberhun:HuntsmanInternationalLLCMember2025-03-31 0001307954hun:AccountsReceivableProgramsMemberhun:HuntsmanInternationalLLCMemberus-gaap:AssetPledgedAsCollateralMember2025-03-31 0001307954hun:AccountsReceivableProgramsMemberhun:HuntsmanInternationalLLCMemberus-gaap:AssetPledgedAsCollateralMember2024-12-31 0001307954hun:ArabianAminesCompanyMember2025-03-31 utr:Y 0001307954us-gaap:ForeignExchangeContractMember2025-01-012025-03-31 0001307954us-gaap:ForeignExchangeContractMember2025-03-31 0001307954us-gaap:ForeignExchangeContractMember2024-03-31 0001307954us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2025-03-31 0001307954us-gaap:CrossCurrencyInterestRateContractMember2025-03-31 0001307954us-gaap:CarryingReportedAmountFairValueDisclosureMember2025-03-31 0001307954us-gaap:EstimateOfFairValueFairValueDisclosureMember2025-03-31 0001307954us-gaap:CarryingReportedAmountFairValueDisclosureMember2024-12-31 0001307954us-gaap:EstimateOfFairValueFairValueDisclosureMember2024-12-31 0001307954us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2025-03-31 0001307954us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2025-03-31 0001307954us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2024-12-31 0001307954us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2024-12-31 0001307954us-gaap:OperatingSegmentsMemberhun:PolyurethanesMemberhun:USAndCanadaMember2025-01-012025-03-31 0001307954us-gaap:OperatingSegmentsMemberhun:PerformanceProductsMemberhun:USAndCanadaMember2025-01-012025-03-31 0001307954us-gaap:OperatingSegmentsMemberhun:AdvancedMaterialsMemberhun:USAndCanadaMember2025-01-012025-03-31 0001307954hun:CorporateAndReconcilingItemsMemberhun:USAndCanadaMember2025-01-012025-03-31 0001307954hun:USAndCanadaMember2025-01-012025-03-31 0001307954us-gaap:OperatingSegmentsMemberhun:PolyurethanesMembersrt:EuropeMember2025-01-012025-03-31 0001307954us-gaap:OperatingSegmentsMemberhun:PerformanceProductsMembersrt:EuropeMember2025-01-012025-03-31 0001307954us-gaap:OperatingSegmentsMemberhun:AdvancedMaterialsMembersrt:EuropeMember2025-01-012025-03-31 0001307954hun:CorporateAndReconcilingItemsMembersrt:EuropeMember2025-01-012025-03-31 0001307954srt:EuropeMember2025-01-012025-03-31 0001307954us-gaap:OperatingSegmentsMemberhun:PolyurethanesMembersrt:AsiaPacificMember2025-01-012025-03-31 0001307954us-gaap:OperatingSegmentsMemberhun:PerformanceProductsMembersrt:AsiaPacificMember2025-01-012025-03-31 0001307954us-gaap:OperatingSegmentsMemberhun:AdvancedMaterialsMembersrt:AsiaPacificMember2025-01-012025-03-31 0001307954hun:CorporateAndReconcilingItemsMembersrt:AsiaPacificMember2025-01-012025-03-31 0001307954srt:AsiaPacificMember2025-01-012025-03-31 0001307954us-gaap:OperatingSegmentsMemberhun:PolyurethanesMemberhun:RestOfWorldMember2025-01-012025-03-31 0001307954us-gaap:OperatingSegmentsMemberhun:PerformanceProductsMemberhun:RestOfWorldMember2025-01-012025-03-31 0001307954us-gaap:OperatingSegmentsMemberhun:AdvancedMaterialsMemberhun:RestOfWorldMember2025-01-012025-03-31 0001307954hun:CorporateAndReconcilingItemsMemberhun:RestOfWorldMember2025-01-012025-03-31 0001307954hun:RestOfWorldMember2025-01-012025-03-31 0001307954us-gaap:OperatingSegmentsMemberhun:DiversifiedMemberhun:PolyurethanesMember2025-01-012025-03-31 0001307954us-gaap:OperatingSegmentsMemberhun:DiversifiedMemberhun:PerformanceProductsMember2025-01-012025-03-31 0001307954hun:DiversifiedMember2025-01-012025-03-31 0001307954us-gaap:OperatingSegmentsMemberhun:SpecialtyMemberhun:AdvancedMaterialsMember2025-01-012025-03-31 0001307954hun:SpecialtyMember2025-01-012025-03-31 0001307954us-gaap:OperatingSegmentsMemberus-gaap:ProductAndServiceOtherMemberhun:AdvancedMaterialsMember2025-01-012025-03-31 0001307954us-gaap:ProductAndServiceOtherMember2025-01-012025-03-31 0001307954us-gaap:OperatingSegmentsMemberhun:PolyurethanesMemberhun:USAndCanadaMember2024-01-012024-03-31 0001307954us-gaap:OperatingSegmentsMemberhun:PerformanceProductsMemberhun:USAndCanadaMember2024-01-012024-03-31 0001307954us-gaap:OperatingSegmentsMemberhun:AdvancedMaterialsMemberhun:USAndCanadaMember2024-01-012024-03-31 0001307954hun:CorporateAndReconcilingItemsMemberhun:USAndCanadaMember2024-01-012024-03-31 0001307954hun:USAndCanadaMember2024-01-012024-03-31 0001307954us-gaap:OperatingSegmentsMemberhun:PolyurethanesMembersrt:EuropeMember2024-01-012024-03-31 0001307954us-gaap:OperatingSegmentsMemberhun:PerformanceProductsMembersrt:EuropeMember2024-01-012024-03-31 0001307954us-gaap:OperatingSegmentsMemberhun:AdvancedMaterialsMembersrt:EuropeMember2024-01-012024-03-31 0001307954hun:CorporateAndReconcilingItemsMembersrt:EuropeMember2024-01-012024-03-31 0001307954srt:EuropeMember2024-01-012024-03-31 0001307954us-gaap:OperatingSegmentsMemberhun:PolyurethanesMembersrt:AsiaPacificMember2024-01-012024-03-31 0001307954us-gaap:OperatingSegmentsMemberhun:PerformanceProductsMembersrt:AsiaPacificMember2024-01-012024-03-31 0001307954us-gaap:OperatingSegmentsMemberhun:AdvancedMaterialsMembersrt:AsiaPacificMember2024-01-012024-03-31 0001307954hun:CorporateAndReconcilingItemsMembersrt:AsiaPacificMember2024-01-012024-03-31 0001307954srt:AsiaPacificMember2024-01-012024-03-31 0001307954us-gaap:OperatingSegmentsMemberhun:PolyurethanesMemberhun:RestOfWorldMember2024-01-012024-03-31 0001307954us-gaap:OperatingSegmentsMemberhun:PerformanceProductsMemberhun:RestOfWorldMember2024-01-012024-03-31 0001307954us-gaap:OperatingSegmentsMemberhun:AdvancedMaterialsMemberhun:RestOfWorldMember2024-01-012024-03-31 0001307954hun:CorporateAndReconcilingItemsMemberhun:RestOfWorldMember2024-01-012024-03-31 0001307954hun:RestOfWorldMember2024-01-012024-03-31 0001307954us-gaap:OperatingSegmentsMemberhun:PolyurethanesMember2024-01-012024-03-31 0001307954us-gaap:OperatingSegmentsMemberhun:PerformanceProductsMember2024-01-012024-03-31 0001307954us-gaap:OperatingSegmentsMemberhun:AdvancedMaterialsMember2024-01-012024-03-31 0001307954hun:CorporateAndReconcilingItemsMember2024-01-012024-03-31 0001307954us-gaap:OperatingSegmentsMemberhun:DiversifiedMemberhun:PolyurethanesMember2024-01-012024-03-31 0001307954us-gaap:OperatingSegmentsMemberhun:DiversifiedMemberhun:PerformanceProductsMember2024-01-012024-03-31 0001307954hun:DiversifiedMember2024-01-012024-03-31 0001307954us-gaap:OperatingSegmentsMemberhun:SpecialtyMemberhun:AdvancedMaterialsMember2024-01-012024-03-31 0001307954hun:SpecialtyMember2024-01-012024-03-31 0001307954us-gaap:OperatingSegmentsMemberus-gaap:ProductAndServiceOtherMemberhun:AdvancedMaterialsMember2024-01-012024-03-31 0001307954us-gaap:ProductAndServiceOtherMember2024-01-012024-03-31 0001307954hun:DefinedBenefitPlansMember2025-01-012025-03-31 0001307954hun:DefinedBenefitPlansMember2024-01-012024-03-31 0001307954us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2025-01-012025-03-31 0001307954us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2024-01-012024-03-31 0001307954hun:ShareRepurchaseProgram2021Member2021-10-26 0001307954hun:ShareRepurchaseProgram2021Member2022-03-25 0001307954hun:ShareRepurchaseProgram2021Member2025-01-012025-03-31 0001307954hun:ShareRepurchaseProgram2021Member2025-03-31 0001307954us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2024-12-31 0001307954us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2024-12-31 0001307954hun:AccumulatedOtherComprehensiveIncomeOtherNetIncludingPortionAttributableToNoncontrollingInterestMember2024-12-31 0001307954hun:AccumulatedOtherComprehensiveIncomeLossUnconsolidatedAffiliatesIncludingPortionAttributableToNoncontrollingInterestMember2024-12-31 0001307954us-gaap:AociAttributableToNoncontrollingInterestMember2024-12-31 0001307954us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2025-01-012025-03-31 0001307954us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2025-01-012025-03-31 0001307954hun:AccumulatedOtherComprehensiveIncomeOtherNetIncludingPortionAttributableToNoncontrollingInterestMember2025-01-012025-03-31 0001307954hun:AccumulatedOtherComprehensiveIncomeLossUnconsolidatedAffiliatesIncludingPortionAttributableToNoncontrollingInterestMember2025-01-012025-03-31 0001307954us-gaap:AociAttributableToNoncontrollingInterestMember2025-01-012025-03-31 0001307954us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2025-03-31 0001307954us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2025-03-31 0001307954hun:AccumulatedOtherComprehensiveIncomeOtherNetIncludingPortionAttributableToNoncontrollingInterestMember2025-03-31 0001307954hun:AccumulatedOtherComprehensiveIncomeLossUnconsolidatedAffiliatesIncludingPortionAttributableToNoncontrollingInterestMember2025-03-31 0001307954us-gaap:AociAttributableToNoncontrollingInterestMember2025-03-31 00013079542025-01-01 0001307954us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2023-12-31 0001307954us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2023-12-31 0001307954hun:AccumulatedOtherComprehensiveIncomeOtherNetIncludingPortionAttributableToNoncontrollingInterestMember2023-12-31 0001307954hun:AccumulatedOtherComprehensiveIncomeLossUnconsolidatedAffiliatesIncludingPortionAttributableToNoncontrollingInterestMember2023-12-31 0001307954us-gaap:AociAttributableToNoncontrollingInterestMember2023-12-31 0001307954us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2024-01-012024-03-31 0001307954us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2024-01-012024-03-31 0001307954hun:AccumulatedOtherComprehensiveIncomeOtherNetIncludingPortionAttributableToNoncontrollingInterestMember2024-01-012024-03-31 0001307954hun:AccumulatedOtherComprehensiveIncomeLossUnconsolidatedAffiliatesIncludingPortionAttributableToNoncontrollingInterestMember2024-01-012024-03-31 0001307954us-gaap:AociAttributableToNoncontrollingInterestMember2024-01-012024-03-31 0001307954us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2024-03-31 0001307954us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2024-03-31 0001307954hun:AccumulatedOtherComprehensiveIncomeOtherNetIncludingPortionAttributableToNoncontrollingInterestMember2024-03-31 0001307954hun:AccumulatedOtherComprehensiveIncomeLossUnconsolidatedAffiliatesIncludingPortionAttributableToNoncontrollingInterestMember2024-03-31 0001307954us-gaap:AociAttributableToNoncontrollingInterestMember2024-03-31 00013079542024-01-01 0001307954us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceIncludingPortionAttributableToNoncontrollingInterestMember2025-01-012025-03-31 0001307954us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceIncludingPortionAttributableToNoncontrollingInterestMember2024-01-012024-03-31 0001307954hun:AccumulatedDefinedBenefitPlansAdjustmentActuarialGainLossIncludingPortionAttributableToNoncontrollingInterestMember2025-01-012025-03-31 0001307954hun:AccumulatedDefinedBenefitPlansAdjustmentActuarialGainLossIncludingPortionAttributableToNoncontrollingInterestMember2024-01-012024-03-31 0001307954hun:AccumulatedDefinedBenefitPlansAdjustmentSettlementGainLossIncludingPortionAttributableToNoncontrollingInterest1Member2025-01-012025-03-31 0001307954hun:AccumulatedDefinedBenefitPlansAdjustmentSettlementGainLossIncludingPortionAttributableToNoncontrollingInterest1Member2024-01-012024-03-31 0001307954hun:HuntsmanInternationalLLCMemberus-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2024-12-31 0001307954hun:HuntsmanInternationalLLCMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2024-12-31 0001307954hun:HuntsmanInternationalLLCMemberhun:AccumulatedOtherComprehensiveIncomeOtherNetIncludingPortionAttributableToNoncontrollingInterestMember2024-12-31 0001307954hun:HuntsmanInternationalLLCMemberhun:AccumulatedOtherComprehensiveIncomeLossUnconsolidatedAffiliatesIncludingPortionAttributableToNoncontrollingInterestMember2024-12-31 0001307954hun:HuntsmanInternationalLLCMemberus-gaap:AociAttributableToNoncontrollingInterestMember2024-12-31 0001307954hun:HuntsmanInternationalLLCMemberus-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2025-01-012025-03-31 0001307954hun:HuntsmanInternationalLLCMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2025-01-012025-03-31 0001307954hun:HuntsmanInternationalLLCMemberhun:AccumulatedOtherComprehensiveIncomeOtherNetIncludingPortionAttributableToNoncontrollingInterestMember2025-01-012025-03-31 0001307954hun:HuntsmanInternationalLLCMemberhun:AccumulatedOtherComprehensiveIncomeLossUnconsolidatedAffiliatesIncludingPortionAttributableToNoncontrollingInterestMember2025-01-012025-03-31 0001307954hun:HuntsmanInternationalLLCMemberus-gaap:AociAttributableToNoncontrollingInterestMember2025-01-012025-03-31 0001307954hun:HuntsmanInternationalLLCMemberus-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2025-03-31 0001307954hun:HuntsmanInternationalLLCMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2025-03-31 0001307954hun:HuntsmanInternationalLLCMemberhun:AccumulatedOtherComprehensiveIncomeOtherNetIncludingPortionAttributableToNoncontrollingInterestMember2025-03-31 0001307954hun:HuntsmanInternationalLLCMemberhun:AccumulatedOtherComprehensiveIncomeLossUnconsolidatedAffiliatesIncludingPortionAttributableToNoncontrollingInterestMember2025-03-31 0001307954hun:HuntsmanInternationalLLCMemberus-gaap:AociAttributableToNoncontrollingInterestMember2025-03-31 0001307954hun:HuntsmanInternationalLLCMember2025-01-01 0001307954hun:HuntsmanInternationalLLCMemberus-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2023-12-31 0001307954hun:HuntsmanInternationalLLCMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2023-12-31 0001307954hun:HuntsmanInternationalLLCMemberhun:AccumulatedOtherComprehensiveIncomeOtherNetIncludingPortionAttributableToNoncontrollingInterestMember2023-12-31 0001307954hun:HuntsmanInternationalLLCMemberhun:AccumulatedOtherComprehensiveIncomeLossUnconsolidatedAffiliatesIncludingPortionAttributableToNoncontrollingInterestMember2023-12-31 0001307954hun:HuntsmanInternationalLLCMemberus-gaap:AociAttributableToNoncontrollingInterestMember2023-12-31 0001307954hun:HuntsmanInternationalLLCMemberus-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2024-01-012024-03-31 0001307954hun:HuntsmanInternationalLLCMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2024-01-012024-03-31 0001307954hun:HuntsmanInternationalLLCMemberhun:AccumulatedOtherComprehensiveIncomeOtherNetIncludingPortionAttributableToNoncontrollingInterestMember2024-01-012024-03-31 0001307954hun:HuntsmanInternationalLLCMemberhun:AccumulatedOtherComprehensiveIncomeLossUnconsolidatedAffiliatesIncludingPortionAttributableToNoncontrollingInterestMember2024-01-012024-03-31 0001307954hun:HuntsmanInternationalLLCMemberus-gaap:AociAttributableToNoncontrollingInterestMember2024-01-012024-03-31 0001307954hun:HuntsmanInternationalLLCMemberus-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2024-03-31 0001307954hun:HuntsmanInternationalLLCMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2024-03-31 0001307954hun:HuntsmanInternationalLLCMemberhun:AccumulatedOtherComprehensiveIncomeOtherNetIncludingPortionAttributableToNoncontrollingInterestMember2024-03-31 0001307954hun:HuntsmanInternationalLLCMemberhun:AccumulatedOtherComprehensiveIncomeLossUnconsolidatedAffiliatesIncludingPortionAttributableToNoncontrollingInterestMember2024-03-31 0001307954hun:HuntsmanInternationalLLCMemberus-gaap:AociAttributableToNoncontrollingInterestMember2024-03-31 0001307954hun:HuntsmanInternationalLLCMember2024-01-01 0001307954hun:HuntsmanInternationalLLCMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceIncludingPortionAttributableToNoncontrollingInterestMember2025-01-012025-03-31 0001307954hun:HuntsmanInternationalLLCMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceIncludingPortionAttributableToNoncontrollingInterestMember2024-01-012024-03-31 0001307954hun:HuntsmanInternationalLLCMemberhun:AccumulatedDefinedBenefitPlansAdjustmentActuarialGainLossIncludingPortionAttributableToNoncontrollingInterestMember2025-01-012025-03-31 0001307954hun:HuntsmanInternationalLLCMemberhun:AccumulatedDefinedBenefitPlansAdjustmentActuarialGainLossIncludingPortionAttributableToNoncontrollingInterestMember2024-01-012024-03-31 0001307954hun:HuntsmanInternationalLLCMemberhun:AccumulatedDefinedBenefitPlansAdjustmentSettlementGainLossIncludingPortionAttributableToNoncontrollingInterest1Member2025-01-012025-03-31 0001307954hun:HuntsmanInternationalLLCMemberhun:AccumulatedDefinedBenefitPlansAdjustmentSettlementGainLossIncludingPortionAttributableToNoncontrollingInterest1Member2024-01-012024-03-31 0001307954hun:PraxairlindeMember2025-02-062025-02-06 0001307954hun:PraxairlindeMember2025-01-012025-03-31 0001307954hun:PraxairlindeMember2025-03-31 0001307954hun:The2016StockIncentivePlanMember2025-03-31 0001307954us-gaap:EmployeeStockOptionMemberhun:The2016StockIncentivePlanMembersrt:MaximumMember2025-01-012025-03-31 0001307954hun:The2016StockIncentivePlanMember2025-01-012025-03-31 0001307954us-gaap:EmployeeStockOptionMember2025-03-31 0001307954hun:PerformanceShareUnitType1Member2025-01-012025-03-31 0001307954hun:PerformanceShareUnitType1Member2024-01-012024-03-31 0001307954hun:EquityAwardsMember2024-12-31 0001307954hun:LiabilityAwardsMember2024-12-31 0001307954hun:EquityAwardsMember2025-01-012025-03-31 0001307954hun:LiabilityAwardsMember2025-01-012025-03-31 0001307954hun:EquityAwardsMember2025-03-31 0001307954hun:LiabilityAwardsMember2025-03-31 0001307954us-gaap:RestrictedStockUnitsRSUMember2025-01-012025-03-31 0001307954us-gaap:PerformanceSharesMember2025-01-012025-03-31 0001307954hun:NonvestedSharesMember2025-03-31 0001307954hun:NonvestedSharesMember2025-01-012025-03-31 0001307954hun:NonvestedSharesMember2024-01-012024-03-31 0001307954hun:HuntsmanInternationalLLCMemberhun:PraxairlindeMember2025-01-012025-03-31 0001307954us-gaap:StockCompensationPlanMember2025-01-012025-03-31 0001307954us-gaap:StockCompensationPlanMember2024-01-012024-03-31 0001307954hun:StockCompensationPlanFromReportedLossMember2025-01-012025-03-31 0001307954hun:StockCompensationPlanFromReportedLossMember2024-01-012024-03-31 0001307954us-gaap:OperatingSegmentsMember2025-01-012025-03-31 0001307954us-gaap:OperatingSegmentsMember2024-01-012024-03-31 0001307954us-gaap:OperatingSegmentsMemberhun:HuntsmanInternationalLLCMemberhun:PolyurethanesMember2025-01-012025-03-31 0001307954us-gaap:OperatingSegmentsMemberhun:HuntsmanInternationalLLCMemberhun:PerformanceProductsMember2025-01-012025-03-31 0001307954us-gaap:OperatingSegmentsMemberhun:HuntsmanInternationalLLCMemberhun:AdvancedMaterialsMember2025-01-012025-03-31 0001307954us-gaap:OperatingSegmentsMemberhun:HuntsmanInternationalLLCMember2025-01-012025-03-31 0001307954us-gaap:OperatingSegmentsMemberhun:HuntsmanInternationalLLCMemberhun:PolyurethanesMember2024-01-012024-03-31 0001307954us-gaap:OperatingSegmentsMemberhun:HuntsmanInternationalLLCMemberhun:PerformanceProductsMember2024-01-012024-03-31 0001307954us-gaap:OperatingSegmentsMemberhun:HuntsmanInternationalLLCMemberhun:AdvancedMaterialsMember2024-01-012024-03-31 0001307954us-gaap:OperatingSegmentsMemberhun:HuntsmanInternationalLLCMember2024-01-012024-03-31 0001307954us-gaap:OperatingSegmentsMember2025-03-31 0001307954us-gaap:OperatingSegmentsMember2024-12-31 0001307954us-gaap:VariableInterestEntityPrimaryBeneficiaryMemberhun:HuntsmanInternationalLLCMember2025-03-31 0001307954us-gaap:VariableInterestEntityPrimaryBeneficiaryMemberhun:HuntsmanInternationalLLCMember2024-12-31
 

                                  

Table of Contents



UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION 

WASHINGTON, D.C. 20549

 

Form 10-Q

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2025

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                          to                         

Commission
file number

    

Exact name of registrant as specified in its charter,
principal office address and telephone number

    

State of
incorporation
or organization

    

I.R.S. employer
identification no.

001-32427

Huntsman Corporation
10003 Woodloch Forest Drive
The Woodlands, Texas 77380
(281) 719-6000

Delaware

42-1648585

333-85141

Huntsman International LLC
10003 Woodloch Forest Drive
The Woodlands, Texas 77380
(281) 719-6000

Delaware

87-0630358

 


Securities registered pursuant to Section 12(b) of the Act:

Registrant

 

Title of each class

 

Trading symbol

Name of each exchange on which registered

Huntsman Corporation

 

Common Stock, par value $0.01 per share

 

HUN

New York Stock Exchange

Huntsman International LLC

 

NONE

 

NONE

NONE

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Huntsman Corporation

Yes ☒

No ☐

Huntsman International LLC

Yes

No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Huntsman Corporation

Yes

No ☐

Huntsman International LLC

Yes

No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):

Huntsman Corporation

Large accelerated filer

Accelerated filer ☐

Non-accelerated filer ☐

Smaller reporting company

Emerging growth company

Huntsman International LLC

Large accelerated filer ☐

Accelerated filer ☐

Non-accelerated filer

Smaller reporting company

Emerging Growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Huntsman Corporation

Huntsman International LLC

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Huntsman Corporation

Yes

No ☒

Huntsman International LLC

Yes

No ☒

On April 23, 2025, 173,745,629 shares of common stock of Huntsman Corporation were outstanding and 2,728 units of membership interest of Huntsman International LLC were outstanding. There is no trading market for Huntsman International LLC’s units of membership interest. All of Huntsman International LLC’s units of membership interest are held by Huntsman Corporation.


This Quarterly Report on Form 10-Q presents information for two registrants: Huntsman Corporation and Huntsman International LLC. Huntsman International LLC is a wholly-owned subsidiary of Huntsman Corporation and is the principal operating company of Huntsman Corporation. The information reflected in this Quarterly Report on Form 10-Q is equally applicable to both Huntsman Corporation and Huntsman International LLC, except where otherwise indicated. Huntsman International LLC meets the conditions set forth in General Instructions H(1)(a) and (b) of Form 10-Q and, to the extent applicable, is therefore filing this form with a reduced disclosure format.



 

 

 
 

HUNTSMAN CORPORATION AND SUBSIDIARIES

HUNTSMAN INTERNATIONAL LLC AND SUBSIDIARIES

QUARTERLY REPORT ON FORM 10-Q FOR THE QUARTERLY PERIOD

ENDED March 31, 2025

TABLE OF CONTENTS

Page

PART I.

FINANCIAL INFORMATION

4

ITEM 1.

Condensed Consolidated Financial Statements (Unaudited)

4

Huntsman Corporation and Subsidiaries:

Unaudited Condensed Consolidated Balance Sheets

4

Unaudited Condensed Consolidated Statements of Operations

5

Unaudited Condensed Consolidated Statements of Comprehensive Income (Loss)

6

Unaudited Condensed Consolidated Statements of Equity

7

Unaudited Condensed Consolidated Statements of Cash Flows

8

Huntsman International LLC and Subsidiaries:

Unaudited Condensed Consolidated Balance Sheets

9

Unaudited Condensed Consolidated Statements of Operations

10

Unaudited Condensed Consolidated Statements of Comprehensive Income (Loss)

11

Unaudited Condensed Consolidated Statements of Equity

12

Unaudited Condensed Consolidated Statements of Cash Flows

13

Huntsman Corporation and Subsidiaries and Huntsman International LLC and Subsidiaries:

Notes to Unaudited Condensed Consolidated Financial Statements

14

ITEM 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

35

ITEM 3.

Quantitative and Qualitative Disclosures About Market Risk

44

ITEM 4.

Controls and Procedures

44

PART II,

OTHER INFORMATION

45

ITEM 1.

Legal Proceedings

45

ITEM 1A.

Risk Factors

45

ITEM 2.

Unregistered Sales of Equity Securities and Use of Proceeds

45

ITEM 6.

Exhibits

46

2

 

FORWARD-LOOKING STATEMENTS

Certain information set forth in this report contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements other than historical factual information are forward-looking statements, including without limitation statements regarding: projections of revenue, expenses, profit, profit margins, tax rates, tax provisions, cash flows, pension and benefit obligations and funding requirements, our liquidity position or other projected financial measures; management’s plans and strategies for future operations, including statements relating to anticipated operating performance, cost reductions, restructuring activities, new product and service developments, competitive strengths or market position, acquisitions, divestitures, spin-offs or other distributions, strategic opportunities, financing activities, stock repurchases, dividends and executive compensation; growth, declines and other trends in markets we sell into; new or modified laws, regulations and accounting pronouncements; outstanding claims, legal proceedings, or the potential outcomes thereof, tax audits and assessments and other contingent liabilities; foreign currency exchange rates and fluctuations in those rates; general economic and capital markets conditions; the timing of any of the foregoing; assumptions underlying any of the foregoing; and any other statements that address events or developments that we intend or believe will or may occur in the future. In some cases, forward-looking statements can be identified by terminology such as “believes,” “expects,” “may,” “will,” “should,” “anticipates” or “intends” or the negative of such terms or other comparable terminology, or by discussions of strategy. We may also make additional forward-looking statements from time to time. All such subsequent forward-looking statements, whether written or oral, by us or on our behalf, are also expressly qualified by these cautionary statements.

All forward-looking statements, including without limitation any projections derived from management’s examination of historical operating trends, are based upon our current expectations and various assumptions. Our expectations, beliefs and projections are expressed in good faith and we believe there is a reasonable basis for them, but there can be no assurance that management’s expectations, beliefs and projections will be achieved. All forward-looking statements apply only as of the date made. We undertake no obligation to publicly update or revise forward-looking statements whether because of new information, future events or otherwise, except as required by securities and other applicable law.

There are a number of risks and uncertainties that could cause our actual results to differ materially from the forward-looking statements contained in or contemplated by this report. Any forward-looking statements should be considered in light of the risks set forth in “Part II. Item 1A. Risk Factors” below and “Part I. Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2024.

 

3

 

 

 

PART I. FINANCIAL INFORMATION

ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

HUNTSMAN CORPORATION AND SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

(In Millions, Except Share and Per Share Amounts)

  

March 31,

  

December 31,

 
  

2025

  

2024

 

ASSETS

        

Current assets:

        

Cash and cash equivalents(1)

 $334  $340 

Accounts and notes receivable (net of allowance for doubtful accounts of $9 and $8, respectively), ($271 and $233 pledged as collateral, respectively)(1)

  789   718 

Accounts receivable from affiliates

  8   7 

Inventories(1)

  1,030   917 

Prepaid expenses

  95   114 

Other current assets

  30   29 

Total current assets

  2,286   2,125 

Property, plant and equipment, net(1)

  2,494   2,493 

Investment in unconsolidated affiliates

  317   346 

Intangible assets, net

  334   344 

Goodwill

  637   633 

Deferred income taxes

  61   69 

Operating lease right-of-use assets

  381   382 

Other noncurrent assets(1)

  722   722 

Total assets

 $7,232  $7,114 
         

LIABILITIES AND EQUITY

        

Current liabilities:

        

Accounts payable(1)

 $723  $758 

Accounts payable to affiliates

  15   12 

Accrued liabilities(1)

  460   416 

Current portion of debt(1)

  284   325 

Current operating lease liabilities(1)

  58   54 

Total current liabilities

  1,540   1,565 

Long-term debt(1)

  1,670   1,510 

Deferred income taxes

  191   204 

Noncurrent operating lease liabilities(1)

  343   348 

Other noncurrent liabilities(1)

  317   324 

Total liabilities

  4,061   3,951 

Commitments and contingencies (Notes 16 and 17)

          

Equity

        

Huntsman Corporation stockholders’ equity:

        

Common stock $0.01 par value, 1,200,000,000 shares authorized, 263,202,496 and 262,751,907 shares issued and 172,595,368 and 172,144,779 shares outstanding, respectively

  3   3 

Additional paid-in capital

  4,260   4,233 

Treasury stock, 90,607,128 shares

  (2,290)  (2,290)

Unearned stock-based compensation

  (48)  (32)

Retained earnings

  2,193   2,245 

Accumulated other comprehensive loss

  (1,167)  (1,200)

Total Huntsman Corporation stockholders’ equity

  2,951   2,959 

Noncontrolling interests in subsidiaries

  220   204 

Total equity

  3,171   3,163 

Total liabilities and equity

 $7,232  $7,114 

 


(1)

At March 31, 2025 and December 31, 2024, respectively, $15 and $6 of cash and cash equivalents, $20 and $19 of accounts and notes receivable (net), $63 and $57 of inventories, $124 each of property, plant and equipment (net), $36 and $37 of other noncurrent assets, $108 and $111 of accounts payable, $17 and $21 of accrued liabilities, $9 each of current portion of debt, $9 and $6 of current operating lease liabilities, $5 and $7 of long-term debt, $13 and $15 of noncurrent operating lease liabilities and $16 each of other noncurrent liabilities from consolidated variable interest entities are included in the respective balance sheet captions above. See “Note 6. Variable Interest Entities.” These assets can only be used to settle obligations of the variable interest entities, and creditors of these liabilities do not have recourse to our general credit.

See accompanying notes to condensed consolidated financial statements.

 

4

 

 

HUNTSMAN CORPORATION AND SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In Millions, Except Per Share Amounts)

 

   

Three months ended

 
   

March 31,

 
   

2025

   

2024

 

Revenues:

               

Trade sales, services and fees, net

  $ 1,374     $ 1,436  

Related party sales

    36       34  

Total revenues

    1,410       1,470  

Cost of goods sold

    1,209       1,269  

Gross profit

    201       201  

Operating expenses:

               

Selling, general and administrative

    166       176  

Research and development

    32       31  

Restructuring, impairment and plant closing costs

    1       11  

Gain on acquisition of assets, net

    (5 )     (52 )

Prepaid asset write-off

          71  

Income associated with litigation matter, net

    (33 )      

Other operating (income) expense, net

    (2 )     2  

Total operating expenses

    159       239  

Operating income (loss)

    42       (38 )

Interest expense, net

    (19 )     (19 )

Equity in income of investment in unconsolidated affiliates

    1       19  

Other income, net

    3       2  

Income (loss) from continuing operations before income taxes

    27       (36 )

Income tax (expense) benefit

    (15 )     20  

Income (loss) from continuing operations

    12       (16 )

Loss from discontinued operations, net of tax

    (1 )     (7 )

Net income (loss)

    11       (23 )

Net income attributable to noncontrolling interests

    (16 )     (14 )

Net loss attributable to Huntsman Corporation

  $ (5 )   $ (37 )
                 

Basic loss per share:

               

Loss from continuing operations attributable to Huntsman Corporation common stockholders

  $ (0.02 )   $ (0.18 )

Loss from discontinued operations attributable to Huntsman Corporation common stockholders, net of tax

    (0.01 )     (0.04 )

Net loss attributable to Huntsman Corporation common stockholders

  $ (0.03 )   $ (0.22 )

Weighted average shares

    172.4       171.8  
                 

Diluted loss per share:

               

Loss from continuing operations attributable to Huntsman Corporation common stockholders

  $ (0.02 )   $ (0.18 )

Loss from discontinued operations attributable to Huntsman Corporation common stockholders, net of tax

    (0.01 )     (0.04 )

Net loss attributable to Huntsman Corporation common stockholders

  $ (0.03 )   $ (0.22 )

Weighted average shares

    172.4       171.8  
                 

Amounts attributable to Huntsman Corporation:

               

Loss from continuing operations

  $ (4 )   $ (30 )

Loss from discontinued operations, net of tax

    (1 )     (7 )

Net loss

  $ (5 )   $ (37 )

See accompanying notes to condensed consolidated financial statements.

5

 

 

HUNTSMAN CORPORATION AND SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(In Millions) 

 

   

Three months ended

 
   

March 31,

 
   

2025

   

2024

 

Net income (loss)

  $ 11     $ (23 )

Other comprehensive income (loss), net of tax:

               

Foreign currency translations adjustments

    35       (36 )

Pension and other postretirement benefits adjustments

    (8 )     8  

Other, net

    6       5  

Other comprehensive income (loss), net of tax

    33       (23 )

Comprehensive income (loss)

    44       (46 )

Comprehensive income attributable to noncontrolling interests

    (16 )     (15 )

Comprehensive income (loss) attributable to Huntsman Corporation

  $ 28     $ (61 )

 

See accompanying notes to condensed consolidated financial statements.

 

6

 

 

HUNTSMAN CORPORATION AND SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF EQUITY

(In Millions, Except Share Amounts)

  

Huntsman Corporation Stockholders' Equity

         
                          

Accumulated

         
  

Shares

      

Additional

      

Unearned

      

other

  

Noncontrolling

     
  

common

  

Common

  

paid-in

  

Treasury

  

stock-based

  

Retained

  

comprehensive

  

interests in

  

Total

 
  

stock

  

stock

  

capital

  

stock

  

compensation

  

earnings

  

loss

  

subsidiaries

  

equity

 

Balance, January 1, 2025

  172,144,779  $3  $4,233  $(2,290) $(32) $2,245  $(1,200) $204  $3,163 

Net (loss) income

                 (5)     16   11 

Other comprehensive income

                    33      33 

Issuance of nonvested stock awards

        25      (25)            

Vesting of stock awards

  626,118      2                  2 

Recognition of stock-based compensation

              9            9 

Repurchase and cancellation of stock awards

  (179,420)              (3)        (3)

Stock options exercised

  3,891                         

Dividends declared on common stock ($0.25 per share)

                 (44)        (44)

Balance, March 31, 2025

 $172,595,368  $3  $4,260  $(2,290) $(48) $2,193  $(1,167) $220  $3,171 

 

  

Huntsman Corporation Stockholders' Equity

         
                          

Accumulated

         
  

Shares

      

Additional

      

Unearned

      

other

  

Noncontrolling

     
  

common

  

Common

  

paid-in

  

Treasury

  

stock-based

  

Retained

  

comprehensive

  

interests in

  

Total

 
  

stock

  

stock

  

capital

  

stock

  

compensation

  

earnings

  

loss

  

subsidiaries

  

equity

 

Balance, January 1, 2024

  171,583,331  $3  $4,202  $(2,290) $(41) $2,622  $(1,245) $227  $3,478 

Net (loss) income

                 (37)     14   (23)

Other comprehensive (loss) income

                    (24)  1   (23)

Issuance of nonvested stock awards

        19      (19)            

Vesting of stock awards

  722,117      2                  2 

Recognition of stock-based compensation

              9            9 

Repurchase and cancellation of stock awards

  (225,895)              (5)        (5)

Stock options exercised

  42,156      8         (8)         

Dividends declared on common stock ($0.25 per share)

                 (44)        (44)

Balance, March 31, 2024

  172,121,709  $3  $4,231  $(2,290) $(51) $2,528  $(1,269) $242  $3,394 

 

See accompanying notes to condensed consolidated financial statements.

7

 

 

HUNTSMAN CORPORATION AND SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In Millions)

 

  

Three months ended

 
  

March 31,

 
  

2025

  

2024

 

Operating activities:

        

Net income (loss)

 $11  $(23)

Less: Loss from discontinued operations, net of tax

  1   7 

Income (loss) from continuing operations

  12   (16)

Adjustments to reconcile income (loss) from continuing operations to net cash used in operating activities from continuing operations:

        

Equity in income of investment in unconsolidated affiliates

  (1)  (19)

Depreciation and amortization

  69   69 

Noncash lease expense

  19   19 

Gain on acquisition of assets, net

  (5)  (52)

Noncash prepaid asset write-off

     71 

Deferred income taxes

  (1)  (33)

Noncash stock-based compensation

  9   9 

Other, net

  3   6 

Changes in operating assets and liabilities:

        

Accounts and notes receivable

  (65)  (87)

Inventories

  (101)  (38)

Prepaid expenses

  26    

Other current assets

  (1)  (1)

Other noncurrent assets

  (3)  (2)

Accounts payable

  (32)  30 

Accrued liabilities

  33   (9)

Other noncurrent liabilities

  (33)  (10)

Net cash used in operating activities from continuing operations

  (71)  (63)

Net cash used in operating activities from discontinued operations

  (3)  (2)

Net cash used in operating activities

  (74)  (65)
         

Investing activities:

        

Capital expenditures

  (36)  (42)

Cash received from return of investment in unconsolidated subsidiary

  41    

Cash received from sale of businesses, net

     12 

Other

  1    

Net cash provided by (used in) investing activities

  6   (30)
         

Financing activities:

        

Net borrowings on revolving loan facilities

  427   191 

Repayments of long-term debt

  (319)  (3)

Principal payments on note payable

     (28)

Dividends paid to common stockholders

  (44)  (44)

Repurchase and cancellation of awards

  (3)  (5)

Repurchase of common stock

     (1)

Other, net

  (1)  (2)

Net cash provided by financing activities

  60   108 

Effect of exchange rate changes on cash

  2   (1)

(Decrease) increase in cash and cash equivalents

  (6)  12 

Cash and cash equivalents at beginning of period

  340   540 

Cash and cash equivalents at end of period

 $334  $552 
         

Supplemental cash flow information:

        

Cash paid for interest

 $8  $12 

Cash paid for income taxes

  12   15 

As of March 31, 2025 and 2024, the amount of capital expenditures in accounts payable was $20 million and $21 million, respectively. 

 

​See accompanying notes to condensed consolidated financial statements.

8

 

 

HUNTSMAN INTERNATIONAL LLC AND SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

(In Millions, Except Unit Amounts)

  

March 31,

  

December 31,

 
  

2025

  

2024

 

ASSETS

        

Current assets:

        

Cash and cash equivalents(1)

 $334  $340 

Accounts and notes receivable (net of allowance for doubtful accounts of $9 and $8, respectively), ($271 and $233 pledged as collateral, respectively)(1)

  789   718 

Accounts receivable from affiliates

  8   7 

Inventories(1)

  1,030   917 

Prepaid expenses

  95   114 

Other current assets

  30   29 

Total current assets

  2,286   2,125 

Property, plant and equipment, net(1)

  2,494   2,493 

Investment in unconsolidated affiliates

  317   346 

Intangible assets, net

  334   344 

Goodwill

  637   633 

Deferred income taxes

  61   69 

Operating lease right-of-use assets

  381   382 

Other noncurrent assets(1)

  722   722 

Total assets

 $7,232  $7,114 
         

LIABILITIES AND EQUITY

        

Current liabilities:

        

Accounts payable(1)

 $723  $758 

Accounts payable to affiliates

  15   12 

Accrued liabilities(1)

  455   411 

Current portion of debt(1)

  284   325 

Current operating lease liabilities(1)

  58   54 

Total current liabilities

  1,535   1,560 

Long-term debt(1)

  1,670   1,510 

Deferred income taxes

  195   207 

Noncurrent operating lease liabilities(1)

  343   348 

Other noncurrent liabilities(1)

  316   319 

Total liabilities

  4,059   3,944 

Commitments and contingencies (Notes 16 and 17)

          

Equity

        

Huntsman International LLC members’ equity:

        

Members’ equity, 2,728 units issued and outstanding

  3,821   3,814 

Retained earnings

  284   337 

Accumulated other comprehensive loss

  (1,152)  (1,185)

Total Huntsman International LLC members’ equity

  2,953   2,966 

Noncontrolling interests in subsidiaries

  220   204 

Total equity

  3,173   3,170 

Total liabilities and equity

 $7,232  $7,114 

 


(1)

At March 31, 2025 and December 31, 2024, respectively, $15 and $6 of cash and cash equivalents, $20 and $19 of accounts and notes receivable (net), $63 and $57 of inventories, $124 each of property, plant and equipment (net), $36 and $37 of other noncurrent assets, $108 and $111 of accounts payable, $17 and $21 of accrued liabilities, $9 each of current portion of debt, $9 and $6 of current operating lease liabilities, $5 and $7 of long-term debt, $13 and $15 of noncurrent operating lease liabilities and $16 each of other noncurrent liabilities from consolidated variable interest entities are included in the respective balance sheet captions above. See “Note 6. Variable Interest Entities.” These assets can only be used to settle obligations of the variable interest entities, and creditors of these liabilities do not have recourse to our general credit.

See accompanying notes to condensed consolidated financial statements.

9

 

 

HUNTSMAN INTERNATIONAL LLC AND SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In Millions)

 

   

Three months ended

 
   

March 31,

 
   

2025

   

2024

 

Revenues:

               

Trade sales, services and fees, net

  $ 1,374     $ 1,436  

Related party sales

    36       34  

Total revenues

    1,410       1,470  

Cost of goods sold

    1,209       1,269  

Gross profit

    201       201  

Operating expenses:

               

Selling, general and administrative

    164       174  

Research and development

    32       31  

Restructuring, impairment and plant closing costs

    1       11  

Gain on acquisition of assets, net

    (5 )     (52 )

Prepaid asset write-off

          71  

Income associated with litigation matter, net

    (33 )      

Other operating (income) expense, net

    (2 )     2  

Total operating expenses

    157       237  

Operating income (loss)

    44       (36 )

Interest expense, net

    (19 )     (19 )

Equity in income of investment in unconsolidated affiliates

    1       19  

Other income, net

    3       2  

Income (loss) from continuing operations before income taxes

    29       (34 )

Income tax (expense) benefit

    (17 )     20  

Income (loss) from continuing operations

    12       (14 )

Loss from discontinued operations, net of tax

    (1 )     (7 )

Net income (loss)

    11       (21 )

Net income attributable to noncontrolling interests

    (16 )     (14 )

Net loss attributable to Huntsman International LLC

  $ (5 )   $ (35 )
                 

Amounts attributable to Huntsman International LLC :

               

Loss from continuing operations

  $ (4 )   $ (28 )

Loss from discontinued operations, net of tax

    (1 )     (7 )

Net loss

  $ (5 )   $ (35 )

 

 

See accompanying notes to condensed consolidated financial statements.

10

 

 

HUNTSMAN INTERNATIONAL LLC AND SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(In Millions)

 

   

Three months ended

 
   

March 31,

 
   

2025

   

2024

 

Net income (loss)

  $ 11     $ (21 )

Other comprehensive income (loss), net of tax:

               

Foreign currency translations adjustments

    35       (36 )

Pension and other postretirement benefits adjustments

    (8 )     8  

Other, net

    6       5  

Other comprehensive income (loss), net of tax

    33       (23 )

Comprehensive income (loss)

    44       (44 )

Comprehensive income attributable to noncontrolling interests

    (16 )     (15 )

Comprehensive income (loss) attributable to Huntsman International LLC

  $ 28     $ (59 )

 

See accompanying notes to condensed consolidated financial statements.

11

 

 

HUNTSMAN INTERNATIONAL LLC AND SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF EQUITY

(In Millions, Except Unit Amounts)

 

  

Huntsman International LLC Members

         
  

Members'

      

Accumulated other

  

Noncontrolling

     
  

equity

      

comprehensive

  

interests in

  

Total

 
  

Units

  

Amount

  

Retained earnings

  

loss

  

subsidiaries

  

equity

 

Balance, January 1, 2025

  2,728  $3,814  $337  $(1,185) $204  $3,170 

Net (loss) income

        (5)     16   11 

Other comprehensive income

           33      33 

Dividends paid to parent

        (43)        (43)

Contribution from parent

     7            7 

Distribution to parent

        (5)        (5)

Balance, March 31, 2025

  2,728   3,821   284   (1,152)  220   3,173 

​  

   

Huntsman International LLC Members

                 
    Members'             Accumulated other     Noncontrolling          
   

equity

           

comprehensive

   

interests in

   

Total

 
   

Units

   

Amount

   

Retained earnings

   

loss

   

subsidiaries

   

equity

 

Balance, January 1, 2024

    2,728     $ 3,785     $ 709     $ (1,230 )   $ 227     $ 3,491  

Net (loss) income

                (35 )           14       (21 )

Other comprehensive (loss) income

                      (24 )     1       (23 )

Dividends paid to parent

                (43 )                 (43 )

Contribution from parent

          8                         8  

Distribution to parent

                (9 )                 (9 )

Balance, March 31, 2024

    2,728       3,793       622       (1,254 )     242       3,403  

See accompanying notes to condensed consolidated financial statements.

12

 

 

HUNTSMAN INTERNATIONAL LLC AND SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In Millions)

 

   

Three months ended

 
   

March 31,

 
   

2025

   

2024

 

Operating activities:

               

Net income (loss)

  $ 11     $ (21 )

Less: Loss from discontinued operations, net of tax

    1       7  

Income (loss) from continuing operations

    12       (14 )

Adjustments to reconcile income (loss) from continuing operations to net cash used in operating activities from continuing operations:

               

Equity in income of investment in unconsolidated affiliates

    (1 )     (19 )

Depreciation and amortization

    69       69  

Noncash lease expense

    19       19  

Gain on acquisition of assets, net

    (5 )     (52 )

Noncash prepaid asset write-off

          71  

Deferred income taxes

          (32 )

Noncash stock-based compensation

    7       8  

Other, net

    5       5  

Changes in operating assets and liabilities:

               

Accounts and notes receivable

    (65 )     (87 )

Inventories

    (101 )     (38 )

Prepaid expenses

    26        

Other current assets

    (1 )     (1 )

Other noncurrent assets

    (3 )     (2 )

Accounts payable

    (32 )     30  

Accrued liabilities

    33       (9 )

Other noncurrent liabilities

    (33 )     (10 )

Net cash used in operating activities from continuing operations

    (70 )     (62 )

Net cash used in operating activities from discontinued operations

    (3 )     (2 )

Net cash used in operating activities

    (73 )     (64 )
                 

Investing activities:

               

Capital expenditures

    (36 )     (42 )

Cash received from return of investment in unconsolidated subsidiary

    41        

Cash received from sale of businesses, net

          12  

Increase in receivable from affiliate

    (5 )     (9 )

Other, net

    1        

Net cash provided by (used in) investing activities

    1       (39 )
                 

Financing activities:

               

Net borrowings on revolving loan facilities

    427       191  

Repayments of long-term debt

    (319 )     (3 )

Principal payments on note payable

          (28 )

Dividends paid to parent

    (43 )     (43 )

Other, net

    (1 )     (1 )

Net cash provided by financing activities

    64       116  

Effect of exchange rate changes on cash

    2       (1 )

(Decrease) increase in cash and cash equivalents

    (6 )     12  

Cash and cash equivalents at beginning of period

    340       540  

Cash and cash equivalents at end of period

  $ 334     $ 552  
                 

Supplemental cash flow information:

               

Cash paid for interest

  $ 8     $ 12  

Cash paid for income taxes

    12       15  

As of March 31, 2025 and 2024, the amount of capital expenditures in accounts payable was $20 million and $21 million, respectively.

 

​See accompanying notes to condensed consolidated financial statements.

13

 

HUNTSMAN CORPORATION AND SUBSIDIARIES

HUNTSMAN INTERNATIONAL LLC AND SUBSIDIARIES

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

1. GENERAL

Certain Definitions

For convenience in this report, the terms “Company,” “Huntsman,” “our,” “us” or “we” may be used to refer to Huntsman Corporation and, unless the context otherwise requires, its subsidiaries and predecessors. In this report, “Huntsman International” refers to Huntsman International LLC (our wholly-owned subsidiary).

In this report, we may use, without definition, the common names of competitors or other industry participants. We may also use the common names or abbreviations for certain chemicals or products.

Interim Financial Statements

Our unaudited interim condensed consolidated financial statements and Huntsman International’s unaudited interim condensed consolidated financial statements were prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP” or “U.S. GAAP”) and in management’s opinion reflect all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of results of operations, comprehensive income (loss), financial position and cash flows for the periods presented. Results for interim periods are not necessarily indicative of those to be expected for the full year. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes to consolidated financial statements included in the Annual Report on Form 10-K for the year ended December 31, 2024 for our Company and Huntsman International.

Description of Businesses

We are a global manufacturer of diversified organic chemical products. We operate in three segments: Polyurethanes, Performance Products and Advanced Materials. Our products comprise many different chemicals and formulations, which we market globally to a wide range of consumers that consist primarily of industrial and building product manufacturers. Our products are used in a broad range of applications, including those in the adhesives, aerospace, automotive, coatings and construction, construction products, durable and non-durable consumer products, electronics, insulation, packaging, power generation and refining. Many of our products offer effects such as premium insulation in homes and buildings and the light weighting of airplanes and automobiles that help conserve energy. We are a leading global producer in many of our key product lines, including MDI, amines, maleic anhydride and epoxy-based polymer formulations. We operate all of our businesses through Huntsman International, our wholly-owned subsidiary. Huntsman International is a Delaware limited liability company and was formed in 1999.

 

Huntsman Corporation and Huntsman International Financial Statements

Except where otherwise indicated, these notes relate to the condensed consolidated financial statements for both our Company and Huntsman International. The differences between our condensed consolidated financial statements and Huntsman International’s condensed consolidated financial statements relate primarily to different capital structures.

​​

Principles of Consolidation

Our condensed consolidated financial statements include the accounts of our wholly-owned and majority-owned subsidiaries and any variable interest entities for which we are the primary beneficiary. Intercompany accounts and transactions have been eliminated.

 

Huntsman International declared and paid to us distributions in the form of certain affiliate accounts receivable during 2025 and 2024.

 

Use of Estimates

 

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

 

14

 
 

2. ACCOUNTING STANDARDS

 

RECENTLY ADOPTED ACCOUNTING STANDARD

 

On January 1, 2025, we adopted Financial Accounting Standards Board (FASB) Accounting Standards Update (ASU) No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures; however, the required disclosures are effective for our 2025 annual reporting period and interim reporting periods within fiscal years beginning after December 15, 2025. We are currently evaluating the impact of the adoption of this accounting standard on the related disclosures.

 

ACCOUNTING STANDARD PENDING ADOPTION IN FUTURE PERIODS

 

The following relevant accounting standard becomes effective subsequent to fiscal year 2025, and we are currently evaluating the impact of the future adoption of this accounting standard on the related disclosures:

 

 

FASB ASU No. 2024-03, Income StatementReporting Comprehensive IncomeExpense Disaggregation Disclosures (Topic 220-40): Disaggregation of Income Statement Expenses, effective for annual reporting periods beginning after December 15, 2026 and interim reporting periods beginning after December 15, 2027

 

 

3. BUSINESS COMBINATIONS AND ACQUISITIONS 

 

SEPARATION AND ACQUISITION OF ASSETS OF SLIC JOINT VENTURE 

 

On January 31, 2024, we completed the planned separation and acquisition of assets of Shanghai Lianheng Isocyanate Company Ltd. (“SLIC”), our joint venture with BASF and three Chinese chemical companies. The final purchase price of the acquired assets was determined based on an asset valuation that was completed in the second quarter of 2024. The acquisition of the assets was funded in part with Huntsman Polyurethanes Shanghai Ltd., our 70%-owned consolidated joint venture in China (“HPS”), issuing a U.S. dollar equivalent note payable at closing of approximately $218 million, which was repaid in full in the second quarter of 2024 using available funds at HPS. During the third quarter of 2024, we received approximately $64 million of cash from SLIC, of which $34 million was a dividend and $30 million was an interim liquidating distribution. Upon the full liquidation of the joint venture during the first quarter of 2025, all remaining cash of SLIC, primarily resulting from the proceeds received by SLIC, was distributed back to the joint venture partners. As such, during the first quarter of 2025, we received approximately $41 million of cash from SLIC, which was our final liquidating distribution.

 

The acquisition has been integrated into our Polyurethanes segment. Transaction costs related to this acquisition were not material during 2024.

 

We have accounted for the acquisition using the acquisition method. As such, we analyzed the fair value of net assets acquired. The allocation of acquisition cost to the assets acquired is summarized as follows (dollars in millions):

 

Fair value of assets acquired:

       

Accounts receivable

  $ 20  

Inventories

    10  

Property, plant and equipment

    231  

Other long-term assets

    24  

Deferred income taxes

    1  

Operating lease right-of-use assets

    3  

Noncurrent operating lease liabilities

    (3 )

Total

  $ 286  

 

The total fair value of the net assets acquired was in excess of the acquisition cost resulting in net gains of approximately $51 million recognized during 2024 and approximately $5 million recognized during the first quarter of 2025. Concurrent with the acquisition of net assets, we wrote off certain prepaid assets of approximately $71 million during 2024 related to operating agreements with SLIC and other joint venture partners.

 

According to the operating agreement of the joint venture, SLIC sold all of its output to the joint venture partners with no external sales. After the separation and acquisition of assets, we use all of the output of the acquired assets for internal use. As such, the acquired business has no external revenues or net income.

 

15

 
 

4. DISCONTINUED OPERATIONS 

 

SaLE of tEXTILE eFFECTS bUSINESS

 

On February 28, 2023, we completed the sale of our textile chemicals and dyes business (“Textile Effects Business”) to Archroma, a portfolio company of SK Capital Partners, and during the first quarter of 2024, we finalized the purchase price valued at $597 million, which included adjustments to the purchase price for working capital, plus the assumption of underfunded pension liabilities. Additionally, during the three months ended March 31, 2025 and 2024, we recorded net charges of approximately $1 million and $8 million, respectively, related to certain post-closing indemnification obligations and other outstanding charges between the parties. 

 

The following table reconciles major line items constituting pretax loss of discontinued operations to after-tax loss of discontinued operations, primarily related to our Textile Effects Business, as presented in our condensed consolidated statements of operations (dollars in millions): 

 

   

Three months ended

 
   

March 31,

 
   

2025

   

2024

 

Major line item constituting pretax loss of discontinued operations:

               

Loss on sale of our Textile Effects Business, net

  $ (1 )   $ (8 )

Loss from discontinued operations before income taxes

    (1 )     (8 )

Income tax benefit

          1  

Net loss attributable to discontinued operations

  $ (1 )   $ (7 )

 

 

5. INVENTORIES

We state our inventories at the lower of cost or market, with cost determined using average cost, last-in first-out (“LIFO”) and first-in first-out methods for different components of inventory. Inventories consisted of the following (dollars in millions):

  March 31,  December 31, 
  

2025

  

2024

 

Raw materials and supplies

 $207  $193 

Work in progress

  40   39 

Finished goods

  828   727 

Total

  1,075   959 

LIFO reserves

  (45)  (42)

Net inventories

 $1,030  $917 

As of both  March 31, 2025 and December 31, 2024, approximately 9% of inventories were recorded using the LIFO cost method.

 

16

​ 
 

6. VARIABLE INTEREST ENTITIES

We evaluate our investments and transactions to identify variable interest entities for which we are the primary beneficiary. We hold a variable interest in the following joint ventures for which we are the primary beneficiary:

 

Rubicon LLC is our 50%-owned joint venture with Lanxess that manufactures products for our Polyurethanes and Performance Products segments.

 

Arabian Amines Company (“AAC”) is our 50%-owned joint venture with Zamil group that manufactures products for our Performance Products segment.

During the three months ended March 31, 2025, there were no changes in our variable interest entities.

Creditors of our variable interest entities have no recourse to our general credit. See “Note 9. Debt—Direct and Subsidiary Debt.” As the primary beneficiary of these variable interest entities at  March 31, 2025, the joint ventures’ assets, liabilities and results of operations are included in our condensed consolidated financial statements.

The following table summarizes the carrying amounts of our variable interest entities’ assets and liabilities included in our condensed consolidated balance sheet as of  March 31, 2025 and our consolidated balance sheet as of  December 31, 2024 (dollars in millions):

   

March 31,

   

December 31,

 
   

2025

   

2024

 

Current assets

  $ 107     $ 89  

Property, plant and equipment, net

    124       124  

Operating lease right-of-use assets

    22       21  

Other noncurrent assets

    135       133  

Deferred income taxes

    10       10  

Total assets

  $ 398     $ 377  

Current liabilities

  $ 143     $ 147  

Long-term debt

    5       7  

Noncurrent operating lease liabilities

    13       15  

Other noncurrent liabilities

    16       16  

Deferred income taxes

    2       2  

Total liabilities

  $ 179     $ 187  

 

Certain operating activities for our variable interest entities for the three months ended March 31, 2025 and 2024 were as follows (dollars in millions):

 

   

Three months ended

 
   

March 31,

 
   

2025

   

2024

 

Income from continuing operations before income taxes

  $ 16     $ 18  

Net cash provided by operating activities

    16       19  

 

17

 
 

7. SUPPLIER FINANCE PROGRAM

 

During the first quarter of 2025, we initiated a supplier finance program that has been made available to certain of our vendors. The program allows our vendors to voluntarily sell their receivables due from us to a participating financial institution on terms that are negotiated between the vendor and the financial institution. The vendor receives payment from the financial institution, and we pay the financial institution on the terms originally negotiated with the vendor, which generally range from 90 to 120 days. We do not pledge assets as security or provide other forms of guarantees associated with this supplier finance program. As of March 31, 2025, outstanding obligations confirmed as valid under this supplier finance program were approximately $22 million, included in accounts payable in our condensed consolidated balance sheets.

 

8. RESTRUCTURING, IMPAIRMENT AND PLANT CLOSING COSTS 

 

As of  March 31, 2025 and December 31, 2024, accrued restructuring and plant closing costs, primarily related to workforce reductions, consisted of the following (dollars in millions):

 

Accrued liabilities as of January 1, 2025

  $ 26  

Charges

     

Payments

    (3 )

Accrued liabilities as of March 31, 2025

  $ 23  

 

As of  March 31, 2025 and December 31, 2024, accrued restructuring and plant closing costs by segment consisted of the following (dollars in millions):

 

           

Performance

   

Advanced

   

Corporate

         
   

Polyurethanes

   

Products

   

Materials

   

and other

   

Total

 

Accrued liabilities as of January 1, 2025

  $ 20     $ 1     $ 4     $ 1     $ 26  

Charges

                             

Payments

    (2 )                 (1 )     (3 )

Accrued liabilities as of March 31, 2025

  $ 18     $ 1     $ 4     $     $ 23  
                                         

Current portion of restructuring reserves

  $ 18     $ 1     $ 1     $     $ 20  

Long-term portion of restructuring reserves

                3             3  

 

Details with respect to cash and noncash restructuring, impairment and plant closing costs from continuing operations for the three months ended March 31, 2025 and 2024 are provided below (dollars in millions):

 

  

Three months ended

 
  

March 31,

 
  

2025

  

2024

 

Cash charges

 $  $8 

Noncash charges (credits):

        

Accelerated depreciation

  2   3 

Other noncash credits

  (1)   

Total restructuring, impairment and plant closing costs

 $1  $11 

 

Restructuring Activities

 

Beginning in the fourth quarter of 2024, our Polyurethanes segment implemented a restructuring program to reduce organizational structure costs. In connection with this restructuring program, we recorded net restructuring expense of approximately $2 million for the three months ended March 31, 2025, primarily related to accelerated depreciation. We expect to record further restructuring expenses of approximately $14 million through 2027, primarily related to accelerated depreciation and site closures.

 

Beginning in the first quarter of 2024, our Advanced Materials segment implemented a restructuring program to optimize the segment’s manufacturing processes and cost structure in the U.S. to better align with future market opportunities. In connection with this restructuring program, we recorded net restructuring expense of approximately $1 million and $8 million during the three months ended  March 31, 2025 and 2024, respectively, primarily related to accelerated depreciation and workforce reductions. We expect to record further restructuring expenses of approximately $7 million through 2027, primarily related to accelerated depreciation.

 

Beginning in the fourth quarter of 2022, we implemented a restructuring program to further realign our cost structure with additional restructuring in Europe. This program was associated with all of our segments and included exiting and consolidating certain facilities, workforce relocation to lower cost locations and further personnel rationalization. In connection with this restructuring program, we recorded net restructuring expense of approximately $2 million during the three months ended  March 31, 2024, primarily related to site closures. 

 

18

 
 

9. DEBT 

Our outstanding debt, net of debt issuance costs, of consolidated entities consisted of the following (dollars in millions):

  

March 31,

  

December 31,

 
  

2025

  

2024

 

Senior credit facilities:

        

Revolving credit facility

 $273  $ 

Senior notes

  1,486   1,799 

Amounts outstanding under A/R programs

  163    

Variable interest entities

  14   16 

Other

  18   20 

Total debt

 $1,954  $1,835 

Current portion of debt

 $284  $325 

Long-term portion of debt

  1,670   1,510 

Total debt

 $1,954  $1,835 

Direct and Subsidiary Debt

Substantially all of our debt, including the facilities described below, has been incurred by our subsidiaries (primarily Huntsman International). Huntsman Corporation is not a guarantor of such subsidiary debt.

Certain of our subsidiaries have third-party debt agreements that contain certain restrictions with regard to dividends, distributions, loans or advances. In certain circumstances, the consent of a third party would be required prior to the transfer of any cash or assets from these subsidiaries to us.

Revolving Credit Facility

 

On May 20, 2022, Huntsman International entered into a $1.2 billion senior unsecured revolving credit facility (the “2022 Revolving Credit Facility”). Borrowings bear interest at the rates specified in the credit agreement governing the 2022 Revolving Credit Facility, which vary based on the type of loan and Huntsman International’s debt ratings. Under the credit agreement, the interest rate margin and the commitment fee rates are also subject to adjustments based on the Company’s performance on specified sustainability target thresholds with respect to annual percentage reduction in operational greenhouse gas emissions intensity and annual percentage reduction in water consumption intensity. Unless previously terminated in accordance with its terms, the 2022 Revolving Credit Facility will mature in May 2027. Huntsman International may increase the 2022 Revolving Credit Facility commitments up to an additional $500 million, subject to the satisfaction of certain conditions. 

 

On February 12, 2025, Huntsman International entered into a First Amendment to the 2022 Revolving Credit Facility (the “First Amendment”). The First Amendment amends the financial covenant regarding the leverage ratio of Huntsman International and its subsidiaries to increase the maximum permitted ratio of Consolidated Net Debt to Consolidated EBITDA (as those terms are defined in the 2022 Revolving Credit Facility) through the quarter ending December 31, 2025.

The following table presents certain amounts under our 2022 Revolving Credit Facility as of  March 31, 2025 (monetary amounts in millions):

 

           

Unamortized

        
           

discounts and

        
  

Committed

  

Principal

   

debt issuance

  

Carrying

    

Facility

 

amount

  

outstanding

   

costs

  

value

 

Interest rate(2)

 

Maturity

2022 Revolving Credit Facility

 $1,200  $273 

(1)

 $  $273 

Term Secured Overnight Financing Rate (“SOFR”) plus 1.475%

 

May 2027

 


(1)

On March 31, 2025, we had an additional $3 million (U.S. dollar equivalent) of letters of credit and bank guarantees issued and outstanding under our 2022 Revolving Credit Facility.

(2)

Interest rates on borrowings under the 2022 Revolving Credit Facility vary based on the type of loan and Huntsman International’s debt ratings. The representative interest rate for U.S. dollar borrowings as of March 31, 2025 was 1.475% above Term SOFR.

 

19

 

Senior Notes

 

On  March 28, 2025, we satisfied and discharged our obligations under the indenture governing our 4.25% senior notes due April 2025 (“2025 Senior Notes”) by irrevocably depositing funds sufficient to redeem them in full, which was approximately $315 million, on the maturity date of April 1, 2025.

 

As of  March 31, 2025, our senior notes consisted of the following (monetary amounts in millions): 

 

          

Unamortized

 
          

premiums,

 
          

discounts

 
          

and debt

 

Notes

 

Maturity

 

Interest rate

  

Amount outstanding

 

issuance costs

 

2029 Senior notes

 

May 2029

  4.50% 

$750 ($743 carrying value)

  7 

2031 Senior notes

 

June 2031

  2.95% 

$400 ($398 carrying value)

  2 

2034 Senior notes

 

October 2034

  5.70% 

$350 ($345 carrying value)

  5 

 

A/R Programs

Our U.S. accounts receivable securitization program (“U.S. A/R Program”) and our European accounts receivable securitization program (“EU A/R Program” and collectively with the U.S. A/R Program, “A/R Programs”) are structured so that we transfer certain of our trade receivables to the U.S. special purpose entity (“U.S. SPE”) and the European special purpose entity (“EU SPE”) in transactions intended to be true sales or true contributions. The receivables collateralize debt incurred by the U.S. SPE and the EU SPE.

 

Information regarding our A/R Programs as of March 31, 2025 was as follows (monetary amounts in millions):

    

Maximum funding

  

Amount

   

Facility

 

Maturity

 

availability(1)

  

outstanding

  

Interest rate(2)

U.S. A/R Program

 

January 2027

 $150  $104 

(3)

Applicable rate plus 0.95%

EU A/R Program

 

July 2027

 100  55  

Applicable rate plus 1.45%

    (or approximately $108)  (or approximately $59)   

 


(1)

The amount of actual availability under our A/R Programs may be lower based on the level of eligible receivables sold, changes in the credit ratings of our customers, customer concentration levels and certain characteristics of the accounts receivable being transferred, as defined in the applicable agreements.

(2)

The applicable rate for our U.S. A/R Program is defined by the lender as Term SOFR. The applicable rate for our EU A/R Program is either Term SOFR, EURIBOR or SONIA (Sterling Overnight Interbank Average Rate). 

(3)

As of March 31, 2025, we had approximately $5 million (U.S. dollar equivalent) of letters of credit issued and outstanding under our U.S. A/R Program.

As of March 31, 2025 and December 31, 2024, $271 million and $233 million, respectively, of accounts receivable were pledged as collateral under our A/R Programs.

 

20

 

 

Variable Interest Entity Debt

 

 As of  March 31, 2025, AAC, our consolidated 50%-owned joint venture, had $14 million outstanding under its loan commitments and debt financing arrangements. As of March 31, 2025, we have $9 million classified as current debt and $5 million as long-term debt on our condensed consolidated balance sheets. We do not guarantee these loan commitments, and AAC is not a guarantor of any of our other debt obligations.

 

Debt Issuance Costs

We record debt issuance costs related to a debt liability on the balance sheets as a reduction to the face amount of that debt liability. As of  March 31, 2025 and December 31, 2024, the amount of debt issuance costs directly reducing the debt liability was $8 million and $9 million, respectively. We amortize debt issuance costs using either a straight line or effective interest method, depending on the debt agreement, and record them as interest expense.​

 

Compliance with Covenants

Our 2022 Revolving Credit Facility contains a financial covenant regarding the leverage ratio of Huntsman International and its subsidiaries. The 2022 Revolving Credit Facility also contains other customary covenants and events of default for credit facilities of this type. Upon an event of default that is not cured or waived within any applicable cure periods, in addition to other remedies that may be available to the lenders, the obligations under the 2022 Revolving Credit Facility may be accelerated.

 

The agreements governing our A/R Programs also contain certain receivable performance metrics. Any material failure to meet the applicable A/R Programs’ metrics could lead to an early termination event under the A/R Programs, which could require us to cease our use of such facilities, prohibiting us from additional borrowings against our receivables or, at the discretion of the lenders, requiring that we repay the A/R Programs in full. An early termination event under the A/R Programs would also constitute an event of default under our 2022 Revolving Credit Facility, which could require us to pay off the balance of the 2022 Revolving Credit Facility in full and could result in the loss of our 2022 Revolving Credit Facility. 

 

We believe that we are in compliance with the covenants contained in the agreements governing our material debt instruments, including our 2022 Revolving Credit Facility, our A/R Programs and our senior notes.​ 

 

 

10. DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES 

We are exposed to market risks, such as changes in interest rates, foreign exchange rates and commodity prices. From time to time, we enter into transactions, including transactions involving derivative instruments, to manage certain of these exposures. We also hedge our net investment in certain European operations. Changes in the fair value of the hedge in the net investment of certain European operations are recorded in other accumulated comprehensive loss.

Through our borrowing activities, we are exposed to interest rate risk. Such risk arises due to the structure of our debt portfolio, including the mix of fixed and floating interest rates. Actions taken to reduce interest rate risk include managing the mix and rate characteristics of various interest-bearing liabilities, as well as entering into interest rate derivative instruments. From time to time, we may purchase interest rate swaps and/or other derivative instruments to reduce the impact of changes in interest rates on our floating-rate exposures. Under interest rate swaps, we agree with other parties to exchange, at specified intervals, the difference between fixed-rate and floating-rate interest amounts calculated by reference to an agreed notional principal amount. 

 

Our revenues and expenses are denominated in various foreign currencies, and our cash flows and earnings are thus subject to fluctuations due to exchange rate variations. From time to time, we may enter into foreign currency derivative instruments to minimize the short-term impact of movements in foreign currency rates. Where practicable, we generally net multicurrency cash balances among our subsidiaries to help reduce exposure to foreign currency exchange rates. Certain other exposures may be managed from time to time through financial market transactions, principally through the purchase of spot or forward foreign exchange contracts (generally with maturities of one year or less). We do not hedge our foreign currency exposures in a manner that would eliminate the effect of changes in exchange rates on our cash flows and earnings. As of March 31, 2025 and 2024, we had approximately $107 million and $185 million, respectively, of notional amount (in U.S. dollar equivalents) outstanding in forward foreign currency contracts related to continuing operations.

 

We review our non-U.S. dollar denominated debt and derivative instruments to determine the appropriate amounts designated as hedges. As of March 31, 2025, we have designated approximately €306 million (approximately $330 million) of euro-denominated derivative instruments as a hedge of our net investment. For the three months ended March 31, 2025 and 2024, the amounts recognized on the hedge of our net investment were losses of approximately $12 million and approximately $1 million, respectively, and were recorded in other comprehensive income (loss) in our condensed consolidated statements of comprehensive income (loss).​ 

 

During the third quarter of 2024, we entered into three-year, cross-currency interest rate contracts to swap an aggregate notional amount $350 million for an approximate aggregate notional €315 million. These cross-currency swaps are designated as net investment hedges and designed to hedge the foreign currency exposure of our net investment in certain European operations. Changes in fair value are recorded in accumulated other comprehensive loss to offset the foreign currency translation adjustments related to these investments. As of March 31, 2025, the fair value of these swaps was approximately $6 million. 

 

21

 
 

11. FAIR VALUE

The fair values of our financial instruments were as follows (dollars in millions):

   

March 31, 2025

   

December 31, 2024

 
   

Carrying

   

Estimated

   

Carrying

   

Estimated

 
   

value

   

fair value

   

value

   

fair value

 

Non-qualified employee benefit plan investments

  $ 8     $ 8     $ 11     $ 11  

Cross-currency interest rate contracts

    6       6       18       18  

Long-term debt (including current portion)

    (1,954 )     (1,859 )     (1,835 )     (1,734 )

The carrying amounts reported in the balance sheets of cash and cash equivalents, accounts receivable and accounts payable approximate fair value because of the immediate or short-term maturity of these financial instruments. The fair values of non-qualified employee benefit plan investments are obtained through market observable pricing using prevailing market prices (Level 1). The fair values of our cross-currency interest rate contracts are based on observable inputs other than quoted prices (Level 2). The fair values of our senior notes are based on quoted market prices for the identical liability when traded in an active market (Level 1), and the fair values of all our other outstanding debt are based on observable inputs other than quoted prices (Level 2). The fair value estimates presented herein are based on pertinent information available to management as of  March 31, 2025 and December 31, 2024. Although we are not aware of any factors that would significantly affect the estimated fair value amounts, such amounts have not been comprehensively revalued for purposes of these financial statements since March 31, 2025, and current estimates of fair value may differ significantly from the amounts presented herein.

During the three months ended March 31, 2025, we held no instruments measured at fair value on a recurring basis using significant unobservable inputs (Level 3), and there were no gains or losses (realized and unrealized) included in our earnings for instruments categorized as Level 3 within the fair value hierarchy.

 

12. REVENUE RECOGNITION​ 

 

The following tables disaggregate our revenue from continuing operations by major source for the three months ended March 31, 2025 and 2024 (dollars in millions):

 

           

Performance

   

Advanced

   

Corporate and

         

2025

 

Polyurethanes

   

Products

   

Materials

   

eliminations

   

Total

 

Primary geographic markets(1)

                                       

U.S. and Canada

  $ 356     $ 118     $ 72     $ (3 )   $ 543  

Europe

    215       48       92       (4 )     351  

Asia Pacific

    270       70       66       (1 )     405  

Rest of world

    71       21       19             111  
    $ 912     $ 257     $ 249     $ (8 )   $ 1,410  
                                         

Major product groupings

                                       

Diversified

  $ 912     $ 257                     $ 1,169  

Specialty

                  $ 238               238  

Other

                    11               11  

Eliminations

                          $ (8 )     (8 )
    $ 912     $ 257     $ 249     $ (8 )   $ 1,410  

 

           

Performance

   

Advanced

   

Corporate and

         

2024

 

Polyurethanes

   

Products

   

Materials

   

eliminations

   

Total

 

Primary geographic markets(1)

                                       

U.S. and Canada

  $ 370     $ 137     $ 73     $ (3 )   $ 577  

Europe

    240       61       107       (4 )     404  

Asia Pacific

    243       71       62       (1 )     375  

Rest of world

    73       22       19             114  
    $ 926     $ 291     $ 261     $ (8 )   $ 1,470  
                                         

Major product groupings

                                       

Diversified

  $ 926     $ 291                     $ 1,217  

Specialty

                  $ 246               246  

Other

                    15               15  

Eliminations

                          $ (8 )     (8 )
    $ 926     $ 291     $ 261     $ (8 )   $ 1,470  

 


(1)

Geographic information for revenues is based upon countries into which product is sold.

 

22

 
 

13. EMPLOYEE BENEFIT PLANS 

Components of the net periodic benefit cost from continuing operations for the three months ended March 31, 2025 and 2024 were as follows (dollars in millions):

 

                   

Other postretirement

 
   

Defined benefit plans

   

benefit plans

 
   

Three months ended

   

Three months ended

 
   

March 31,

   

March 31,

 
   

2025

   

2024

   

2025

   

2024

 

Service cost

  $ 6     $ 7     $     $  

Interest cost

    22       22       1       1  

Expected return on assets

    (31 )     (32 )            

Amortization of prior service benefit

    (1 )     (1 )     (1 )     (1 )

Amortization of actuarial loss

    7       8              

Settlement gain

    (1 )                  

Net periodic benefit cost

  $ 2     $ 4     $     $  

During the three months ended March 31, 2025 and 2024, we made contributions to our pension and other postretirement benefit plans related to continuing operations of $8 million and $10 million, respectively. During the remainder of 2025, we expect to contribute an additional amount of approximately $27 million to these plans.

​ 

 

14. HUNTSMAN CORPORATION STOCKHOLDERS’ EQUITY

Share Repurchase Program

On October 26, 2021, our Board of Directors approved a new share repurchase program of $1 billion. On March 25, 2022, our Board of Directors increased the authorization of our share repurchase program from $1 billion to $2 billion. The share repurchase program is supported by our free cash flow generation. Repurchases may be made in the open market, including through accelerated share repurchase programs, or in privately negotiated transactions, and repurchases may be commenced or suspended from time to time without prior notice. Shares of common stock acquired through the repurchase program are held in treasury at cost. During the three months ended March 31, 2025, we did not repurchase any shares of our common stock under this program. As of  March 31, 2025, we have approximately $547 million remaining under the authorization of our existing share repurchase program. 

Dividends on Common Stock

During the three months ended March 31, 2025 and 2024, we declared dividends of $44 million and $43 million, respectively, or $0.25 per share, to common stockholders. 

 

23

 
 

15. ACCUMULATED OTHER COMPREHENSIVE LOSS

The components of other comprehensive income (loss) and changes in accumulated other comprehensive loss by component were as follows (dollars in millions):

Huntsman Corporation

      

Pension

                 
  

Foreign

  

and other

          

Amounts

  

Amounts

 
  

currency

  

postretirement

          

attributable to

  

attributable to

 
  

translation

  

benefits

          

noncontrolling

  

Huntsman

 
  

adjustments(1)

  

adjustments(2)

  

Other, net

  

Total

  

interests

  

Corporation

 

Beginning balance, January 1, 2025

 $(675) $(552) $  $(1,227) $27  $(1,200)

Other comprehensive income (loss) before reclassifications, gross

  32   (12)  6   26      26 

Tax impact

  3         3      3 

Amounts reclassified from accumulated other comprehensive loss, gross(3)

     4      4      4 

Tax impact

                  

Net current-period other comprehensive income (loss)

  35   (8)  6   33      33 

Ending balance, March 31, 2025

 $(640) $(560) $6  $(1,194) $27  $(1,167)

 


(1)

Amounts are net of tax of $57 million and $60 million as of  March 31, 2025 and January 1, 2025, respectively.

(2)

Amounts are net of tax of $61 million as of both  March 31, 2025 and January 1, 2025.

(3)

See tables below for details about pension and other postretirement benefits reclassifications.

      

Pension

                 
  

Foreign

  

and other

          

Amounts

  

Amounts

 
  

currency

  

postretirement

          

attributable to

  

attributable to

 
  

translation

  

benefits

          

noncontrolling

  

Huntsman

 
  

adjustments(1)

  

adjustments(2)

  

Other, net

  

Total

  

interests

  

Corporation

 

Beginning balance, January 1, 2024

 $(614) $(656) $(3) $(1,273) $28  $(1,245)

Other comprehensive (loss) income before reclassifications, gross

  (36)  2   5   (29)  (1)  (30)

Tax impact

                  

Amounts reclassified from accumulated other comprehensive loss, gross(3)

     6      6      6 

Tax impact

                  

Net current-period other comprehensive (loss) income

  (36)  8   5   (23)  (1)  (24)

Ending balance, March 31, 2024

 $(650) $(648) $2  $(1,296) $27  $(1,269)

 


(1)

Amounts are net of tax of $56 million as of both  March 31, 2024 and January 1, 2024.

(2)

Amounts are net of tax of $67 million as of both  March 31, 2024 and January 1, 2024.

(3)

See tables below for details about pension and other postretirement benefits reclassifications.

24

 
  

Three months ended March 31,

   
  

2025

  

2024

   
  

Amounts reclassified

  

Amounts reclassified

  

Affected line item in

  

from accumulated

  

from accumulated

  

the statement

Details about accumulated other

 

other

  

other

  

where net income

comprehensive loss components(1)(2):

 

comprehensive loss

  

comprehensive loss

  

is presented

Amortization of pension and other postretirement benefits:

          

Prior service credit

 $(2) $(2)

(3)

Other income, net

Actuarial loss

  7   8 

(3)

Other income, net

Settlement gain

  (1)   

(3)

Other income, net

   4   6  

Total before tax

        

Income tax (expense) benefit

Total reclassifications for the period

 $4  $6  

Net of tax

 


(1)Details of amounts reclassified from accumulated other comprehensive loss relate only to pension and other postretirement benefits.

 

(2)

Pension and other postretirement benefits amounts in parentheses indicate credits on our condensed consolidated statements of operations.

(3)

These accumulated other comprehensive loss components are included in the computation of net periodic pension costs. See “Note 13. Employee Benefit Plans.”

 

Huntsman International

      

Pension

                 
  

Foreign

  

and other

          

Amounts

  

Amounts

 
  

currency

  

postretirement

          

attributable to

  

attributable to

 
  

translation

  

benefits

          

noncontrolling

  

Huntsman

 
  

adjustments(1)

  

adjustments(2)

  

Other, net

  

Total

  

interests

  

International

 

Beginning balance, January 1, 2025

 $(680) $(528) $(4) $(1,212) $27  $(1,185)

Other comprehensive income (loss) before reclassifications, gross

  32   (12)  6   26      26 

Tax impact

  3         3      3 

Amounts reclassified from accumulated other comprehensive loss, gross(3)

     4      4      4 

Tax impact

                  

Net current-period other comprehensive income (loss)

  35   (8)  6   33      33 

Ending balance, March 31, 2025

 $(645) $(536) $2  $(1,179) $27  $(1,152)

 


(1)

Amounts are net of tax of $44 million and $47 million as of  March 31, 2025 and January 1, 2025, respectively.

 

(2)

Amounts are net of tax of $85 million as of both  March 31, 2025 and January 1, 2025, respectively.

(3)

See tables below for details about pension and other postretirement benefits reclassifications.

25

 
      

Pension

                 
  

Foreign

  

and other

          

Amounts

  

Amounts

 
  

currency

  

postretirement

          

attributable to

  

attributable to

 
  

translation

  

benefits

          

noncontrolling

  

Huntsman

 
  

adjustments(1)

  

adjustments(2)

  

Other, net

  

Total

  

interests

  

International

 

Beginning balance, January 1, 2024

 $(619) $(632) $(7) $(1,258) $28  $(1,230)

Other comprehensive (loss) income before reclassifications, gross

  (36)  2   5   (29)  (1)  (30)

Tax impact

                  

Amounts reclassified from accumulated other comprehensive loss, gross(3)

     6      6      6 

Tax impact

                  

Net current-period other comprehensive (loss) income

  (36)  8   5   (23)  (1)  (24)

Ending balance, March 31, 2024

 $(655) $(624) $(2) $(1,281) $27  $(1,254)

 


(1)

Amounts are net of tax of $43 million as of both  March 31, 2024 and January 1, 2024.

(2)

Amounts are net of tax of $91 million as of both  March 31, 2024 and January 1, 2024.

(3)

See tables below for details about pension and other postretirement benefits reclassifications.

 

  

Three months ended March 31,

   
  

2025

  

2024

   
  

Amounts reclassified

  

Amounts reclassified

  

Affected line item in

  

from accumulated

  

from accumulated

  

the statement

Details about accumulated other

 

other

  

other

  

where net income

comprehensive loss components(1)(2):

 

comprehensive loss

  

comprehensive loss

  

is presented

Amortization of pension and other postretirement benefits:

          

Prior service credit

 $(2) $(2)

(3)

Other income, net

Actuarial loss

  7   8 

(3)

Other income, net

Settlement gain

  (1)   

(3)

Other income, net

   4   6  

Total before tax

        

Income tax (expense) benefit

Total reclassifications for the period

 $4  $6  

Net of tax


(1)Details of amounts reclassified from accumulated other comprehensive loss relate only to pension and other postretirement benefits.

 

(2)

Pension and other postretirement benefits amounts in parentheses indicate credits on our condensed consolidated statements of operations.

(3)

These accumulated other comprehensive loss components are included in the computation of net periodic pension costs. See “Note 13. Employee Benefit Plans.”

 

26

 
 

16. COMMITMENTS AND CONTINGENCIES

Legal Matters

On February 6, 2025, the Louisiana Supreme Court affirmed the jury verdict and district court judgment in our favor in our long-running court battle against Praxair/Linde, one of the industrial gas suppliers to our Geismar, Louisiana MDI manufacturing site, and entered a damages award consistent with Huntsman’s expert witness testimony at trial. The case was filed after Praxair refused to maintain properly its own Geismar facility and then repeatedly failed to supply our requirements for industrial gases needed to manufacture MDI under long-term supply contracts that expired in 2013. During the first quarter of 2025, we received a final award of approximately $66 million, which included mandatory pre-judgment and post-judgment interest of approximately $23.5 million. We recognized income related to this matter of approximately $33 million, net of legal fees, during the first quarter of 2025. We expect to pay cash taxes related to this matter of approximately $8 million in future years.

 

We are a party to various other proceedings instituted by private plaintiffs, governmental authorities and others arising under provisions of applicable laws, including various environmental, products liability and other laws. We do not believe that the outcome of any of these matters will have a material effect on our financial condition, results of operations or liquidity.

 

 

17. ENVIRONMENTAL, HEALTH AND SAFETY MATTERS

EHS Capital Expenditures

 

We may incur future costs for capital improvements and general compliance under environmental, health and safety (“EHS”) laws, including costs to acquire, maintain and repair pollution control equipment. For both the three months ended March 31, 2025 and 2024, our capital expenditures from continuing operations for EHS matters totaled $5 million. Because capital expenditures for these matters are subject to evolving regulatory requirements and depend, in part, on the timing, promulgation and enforcement of specific requirements, our capital expenditures for EHS matters have varied significantly from year to year and we cannot provide assurance that our recent expenditures are indicative of future amounts we may spend related to EHS and other applicable laws.

 

Environmental Reserves

We have accrued liabilities relating to anticipated environmental cleanup obligations, site reclamation and closure costs and known penalties. Liabilities are recorded when potential liabilities are either known or considered probable and can be reasonably estimated. Our liability estimates are calculated using present value techniques as appropriate and are based upon requirements placed upon us by regulators, available facts, existing technology and past experience. The environmental liabilities do not include amounts recorded as asset retirement obligations. We had accrued $15 million for environmental liabilities as of both  March 31, 2025 and December 31, 2024. Of these amounts, $6 million was classified as accrued liabilities as of both  March 31, 2025 and December 31, 2024, and $9 million was classified as other noncurrent liabilities as of both  March 31, 2025 and December 31, 2024. In certain cases, our remediation liabilities may be payable over periods of up to 30 years. We may incur losses for environmental remediation in excess of the amounts accrued; however, we are not able to estimate the amount or range of such potential excess.

 

Environmental Matters

Under the Comprehensive Environmental Response, Compensation, and Liability Act (“CERCLA”) and similar state laws, a current or former owner or operator of real property in the U.S. may be liable for remediation costs regardless of whether the release or disposal of hazardous substances was in compliance with law at the time it occurred, and a current owner or operator may be liable regardless of whether it owned or operated the facility at the time of the release. Outside the U.S., analogous contaminated property laws can hold past owners and/or operators liable for remediation at former facilities. Currently, there are approximately six former facilities or third-party sites in the U.S. for which we have been notified of potential claims against us for cleanup liabilities, including, but not limited to, sites listed under CERCLA. Based on current information and past experiences at other CERCLA sites, we do not expect these third-party claims to have a material impact on our condensed consolidated financial statements.

Under the Resource Conservation and Recovery Act (“RCRA”) in the U.S. and similar state laws, we may be required to remediate contamination originating from our properties. Similar laws exist in a number of non-U.S. locations in which we currently operate, or previously operated, manufacturing facilities. Some of our manufacturing sites have an extended history of industrial chemical manufacturing and use, including on-site waste disposal. We are aware of soil, groundwater or surface contamination from past operations at some of our sites, and we may find contamination at other sites in the future. For example, our Geismar, Louisiana facility is the subject of ongoing remediation requirements imposed under RCRA.

 

27

 
 

18. STOCK-BASED COMPENSATION PLANS

As of March 31, 2025, we had approximately 4 million shares remaining under the stock-based compensation plans available for grant. Option awards have a maximum contractual term of 10 years and generally must have an exercise price at least equal to the market price of our common stock on the date the option award is granted. Outstanding stock-based awards generally vest annually over a three-year period or in total at the end of a three-year period. 

 

The compensation cost from continuing operations under the stock-based compensation plans for our Company and Huntsman International were as follows (dollars in millions):

 

  

Three months ended

 
  

March 31,

 
  

2025

  

2024

 

Huntsman Corporation compensation cost

 $9  $9 

Huntsman International compensation cost

  7   8 

 

The total income tax expense recognized in the condensed consolidated statements of operations for us and Huntsman International for stock-based compensation arrangements was approximately $1 million and nil for the three months ended March 31, 2025 and 2024, respectively.

Stock Options

The fair value of each stock option award was estimated on the date of grant using the Black-Scholes valuation model. Expected volatilities were based on the historical volatility of our common stock through the grant date. The expected term of options granted was estimated based on the contractual term of the instruments and employees’ expected exercise and post-vesting employment termination behavior. The risk-free rate for periods within the contractual life of the option was based on the U.S. Treasury yield curve in effect at the time of grant. 

 

During each of the three months ended March 31, 2025 and 2024, no stock options were granted.

 

A summary of stock option activity under the stock-based compensation plans as of March 31, 2025 and changes during the three months then ended is presented below:

          

Weighted

     
      

Weighted

  

average

     
      

average

  

remaining

  

Aggregate

 
      

exercise

  

contractual

  

intrinsic

 

Option awards

 

Shares

  

price

  

term

  

value

 
  

(in thousands)

      

(years)

  

(in millions)

 

Outstanding at January 1, 2025

  2,414  $22.18         

Exercised

  (8)  8.86         

Forfeited

  (294)  22.77         

Outstanding and exercisable at March 31, 2025

  2,112   22.15   3.4  $2 

28

 

As of  March 31, 2025, there was no unrecognized compensation cost related to nonvested stock option arrangements granted under the stock-based compensation plans. 

 

The total intrinsic value of stock options exercised during the three months ended March 31, 2025 and 2024 was approximately nil and $1 million, respectively. Cash received from stock options exercised during both of the three months ended March 31, 2025 and 2024 was approximately nil. The cash tax benefit from stock options exercised during both of the three months ended March 31, 2025 and 2024 was approximately nil.

 

Nonvested Shares

Nonvested shares granted under the stock-based compensation plans consist of restricted stock and performance share unit awards, which are accounted for as equity awards, and phantom stock, which is accounted for as a liability award because it can be settled in either stock or cash. The fair value of each restricted stock and phantom stock award is estimated to be the closing stock price of Huntsman’s stock on the date of grant.

For our performance share unit awards, the performance criteria are total stockholder return of our common stock relative to the total stockholder return of a specified industry peer group for the three-year performance periods. The fair value of each performance share unit award is estimated using a Monte Carlo simulation model that uses various assumptions, including an expected volatility rate and a risk-free interest rate. For the three months ended March 31, 2025 and 2024, the weighted-average expected volatility rate was 29.9% and 31.8%, respectively, and the weighted average risk-free interest rate was 4.31% and 4.39%, respectively. For the performance share unit awards granted during the three months ended March 31, 2025 and 2024, the number of shares earned varies based upon the Company achieving certain performance criteria over a three-year performance period.

 

A summary of the status of our nonvested shares as of March 31, 2025 and changes during the three months then ended is presented below:

  

Equity awards

  

Liability awards

 
       

Weighted

      

Weighted

 
       

average

      

average

 
       

grant-date

      

grant-date

 
  

Shares

   

fair value

  

Shares

  

fair value

 
  

(in thousands)

       

(in thousands)

     

Nonvested at January 1, 2025

  2,276   $33.22   225  $27.36 

Granted

  1,561    17.63   212   16.98 

Vested

  (594)

(1)(2)

  38.13   (96)  29.51 

Forfeited

  (15)

 

  24.83   (6)  28.68 

Nonvested at March 31, 2025

  3,228    24.82   335   20.16 

 


(1)

As of March 31, 2025, a total of 175,238 restricted stock units were vested but not yet issued, of which 38,868 vested during the three months ended March 31, 2025. These shares have not been reflected as vested shares in this table because, in accordance with the restricted stock unit agreements, shares of common stock are not issued for vested restricted stock units until termination of employment.

 

(2)A total of 186,825 performance share unit awards are reflected in the vested shares in this table, which represents the target number of performance share unit awards for this grant and were included in the balance at December 31, 2024. Due to the target performance criteria not being met, only 123,119 performance share unit awards with a grant date fair value of $60.36 were issued during the three months ended March 31, 2025.

As of March 31, 2025, there was approximately $53 million of total unrecognized compensation cost related to nonvested share compensation arrangements granted under the stock-based compensation plans. That cost is expected to be recognized over a weighted-average period of approximately 2.2 years. The value of share awards that vested during the three months ended March 31, 2025 and 2024 was approximately $25 million and $24 million, respectively.

​ 

29

 
 

19. INCOME TAXES

We use the asset and liability method of accounting for income taxes. Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial and tax reporting purposes. We evaluate deferred tax assets to determine whether it is more likely than not that they will be realized. Valuation allowances are reviewed on an individual tax jurisdiction basis to analyze whether there is sufficient positive or negative evidence to support a change in judgment about the realizability of the related deferred tax assets. These conclusions require significant judgment. In evaluating the objective evidence that historical results provide, we consider the cyclicality of our businesses and cumulative income or losses during the applicable period. Cumulative losses incurred over the applicable period limits our ability to consider other subjective evidence such as our projections for the future. Changes in expected future income in applicable jurisdictions could affect the realization of deferred tax assets in those jurisdictions.

 

Huntsman Corporation

We recorded income tax (expense) benefit from continuing operations of $(15) million and $20 million for the three months ended March 31, 2025 and 2024, respectively. During the first quarter of 2025, we recorded a discrete tax expense of $8 million resulting from income associated with the Praxair litigation and discrete establishments of valuation allowances of approximately $9 million. During the first quarter of 2024, we recorded a discrete tax benefit of $18 million resulting from the write-off of certain prepaid assets related to operating agreements with SLIC and other joint venture partners concurrent with the separation and acquisition of assets of SLIC. Our tax expense is significantly affected by the mix of income and losses in the tax jurisdictions in which we operate, as impacted by the presence of valuation allowances in certain tax jurisdictions. In particular, we recognize tax expense in jurisdictions with pre-tax income but do not recognize a tax benefit from pre-tax losses in jurisdictions with valuation allowances.

 

Huntsman International

Huntsman International recorded income tax (expense) benefit from continuing operations of $(17) million and $20 million for the three months ended March 31, 2025 and 2024, respectively. During the first quarter of 2025, we recorded a discrete tax expense of $8 million resulting from income associated with the Praxair litigation and discrete establishments of valuation allowances of approximately $9 million. During the first quarter of 2024, we recorded a discrete tax benefit of $18 million resulting from the write-off of certain prepaid assets related to operating agreements with SLIC and other joint venture partners concurrent with the separation and acquisition of assets of SLIC. Our tax expense is significantly affected by the mix of income and losses in the tax jurisdictions in which we operate, as impacted by the presence of valuation allowances in certain tax jurisdictions. In particular, we recognize tax expense in jurisdictions with pre-tax income but do not recognize a tax benefit from pre-tax losses in jurisdictions with valuation allowances.

 

 

20. EARNINGS PER SHARE

Basic income per share excludes dilution and is computed by dividing net income attributable to Huntsman Corporation by the weighted average number of shares outstanding during the period. Diluted income per share reflects all potential dilutive common shares outstanding during the period and is computed by dividing net income attributable to Huntsman Corporation by the weighted average number of shares outstanding during the period increased by the number of additional shares that would have been outstanding as potential dilutive securities. Diluted income per share is computed using the treasury stock method for all stock-based awards. In periods with reported loss from continuing operations attributable to Huntsman Corporation, all stock-based awards are generally deemed anti-dilutive and would be excluded from the calculation of diluted income per share from continuing operations, discontinued operations and net income regardless of whether there is income or loss from discontinued operations and net income.

Basic and diluted loss per share were determined using the following information (in millions):

 

   

Three months ended

 
   

March 31,

 
   

2025

   

2024

 

Numerator:

               

Loss from continuing operations attributable to Huntsman Corporation

  $ (4 )   $ (30 )

Net loss attributable to Huntsman Corporation

  $ (5 )   $ (37 )
                 

Denominator:

               

Weighted average shares outstanding

    172.4       171.8  

Dilutive shares:

               

Stock-based awards

           

Total weighted average shares outstanding, including dilutive shares

    172.4       171.8  

 

Additional stock-based awards of approximately 4.6 million and 2.7 million weighted average equivalent shares of stock were outstanding during the three months ended March 31, 2025 and 2024, respectively. However, these stock-based awards were not included in the computation of diluted income per share for the respective periods mentioned above because the effect would be anti-dilutive. For the three months ended  March 31, 2025 and 2024, there were 0.5 million and 0.9 million, respectively, weighted average equivalent shares of stock included in the total anti-dilutive weighted average equivalent shares of stock noted above as a result of the reported loss from continuing operations attributable to Huntsman Corporation.

 

30

 
 

21. OPERATING SEGMENT INFORMATION 

We derive our revenues, earnings and cash flows from the manufacture and sale of a wide variety of diversified organic chemical products. We have three operating segments, which are also our reportable segments: Polyurethanes, Performance Products and Advanced Materials. We have organized our business and derived our operating segments around differences in product lines. 

 

The major products of each reportable operating segment are as follows:

Segment

    

Products

Polyurethanes

MDI, polyols, TPU and other polyurethane-related products

Performance Products

Performance amines, ethyleneamines and maleic anhydride

Advanced Materials

Technologically-advanced epoxy, phenoxy, acrylic, polyurethane and acrylonitrile-butadiene-based polymer formulations; high performance thermoset resins, curing agents, toughening agents, and carbon nanomaterials

 

Sales between segments are generally recognized at external market prices and are eliminated in consolidation. We use adjusted EBITDA to measure the financial performance of our global business units and for reporting the results of our operating segments. This measure includes all operating items relating to the businesses. The adjusted EBITDA of operating segments excludes items that principally apply to our Company as a whole. The following schedule includes revenues, significant segment expenses and adjusted EBITDA for each of our reportable operating segments (dollars in millions). 

 

Huntsman Corporation

  

Three months ended March 31, 2025

 
  

Polyurethanes

  

Performance Products

  

Advanced Materials

  

Total

 

Revenues:

                

Reportable segments’ revenues(1)

 $912  $257  $249  $1,418 
                 

Significant segment expenses:

                

Variable direct costs(2)

  682   137   116   935 

Adjusted fixed costs(3)

  186   84   101   371 

Other segment items(4)

  2   6   (4)  4 

Total reportable segments’ adjusted EBITDA(5)

 $42  $30  $36   108 
                 

Reconciliation of total reportable segments’ adjusted EBITDA to income from continuing operations before income taxes:

                

Interest expense, net—continuing operations

              (19)

Depreciation and amortization—continuing operations

              (69)

Corporate and other costs, net(6)

              (36)

Net income attributable to noncontrolling interests

              16 

Other adjustments:

                

Business acquisition and integration gain and purchase accounting inventory adjustments, net

              5 

Certain legal and other settlements and related income

              33 

Amortization of pension and postretirement actuarial losses

              (7)

Restructuring, impairment and plant closing and transition costs(7)

              (4)

Income from continuing operations before income taxes

              27 
                 

Income tax expense—continuing operations

              (15)

Loss from discontinued operations, net of tax

              (1)

Net income

             $11 

 

31

 
  

Three months ended March 31, 2024

 
  

Polyurethanes

  

Performance Products

  

Advanced Materials

  

Total

 

Revenues:

                

Reportable segments’ revenues(1)

 $926  $291  $261  $1,478 
                 

Significant segment expenses:

                

Variable direct costs(2)

  705   160   122   987 

Adjusted fixed costs(3)

  198   83   98   379 

Other segment items(4)

  (16)  6   (2)  (12)

Total reportable segments’ adjusted EBITDA(5)

 $39  $42  $43   124 
                 

Reconciliation of total reportable segments’ adjusted EBITDA to loss from continuing operations before income taxes:

                

Interest expense, net—continuing operations

              (19)

Depreciation and amortization—continuing operations

              (69)

Corporate and other costs, net(6)

              (43)

Net income attributable to noncontrolling interests

              14 

Other adjustments:

                

Business acquisition and integration expenses and purchase accounting inventory adjustments, net

              (20)

Certain legal and other settlements and related expenses

              (1)

Amortization of pension and postretirement actuarial losses

              (8)

Restructuring, impairment and plant closing and transition costs(7)

              (14)

Loss from continuing operations before income taxes

              (36)
                 

Income tax benefit—continuing operations

              20 

Loss from discontinued operations, net of tax

              (7)

Net loss

             $(23)

 

Huntsman International

  

Three months ended March 31, 2025

 
  

Polyurethanes

  

Performance Products

  

Advanced Materials

  

Total

 

Revenues:

                

Reportable segments’ revenues(1)

 $912  $257  $249  $1,418 
                 

Significant segment expenses:

                

Variable direct costs(2)

  682   137   116   935 

Adjusted fixed costs(3)

  186   84   101   371 

Other segment items(4)

  2   6   (4)  4 

Total reportable segments’ adjusted EBITDA(5)

 $42  $30  $36   108 
                 

Reconciliation of total reportable segments’ adjusted EBITDA to income from continuing operations before income taxes:

                

Interest expense, net—continuing operations

              (19)

Depreciation and amortization—continuing operations

              (69)

Corporate and other costs, net(6)

              (34)

Net income attributable to noncontrolling interests

              16 

Other adjustments:

                

Business acquisition and integration gain and purchase accounting inventory adjustments, net

              5 

Certain legal and other settlements and related income

              33 

Amortization of pension and postretirement actuarial losses

              (7)

Restructuring, impairment and plant closing and transition costs(7)

              (4)

Income from continuing operations before income taxes

              29 
                 

Income tax expense—continuing operations

              (17)

Loss from discontinued operations, net of tax

              (1)

Net income

             $11 

 

32

 
  

Three months ended March 31, 2024

 
  

Polyurethanes

  

Performance Products

  

Advanced Materials

  

Total

 

Revenues:

                

Reportable segments’ revenues(1)

 $926  $291  $261  $1,478 
                 

Significant segment expenses:

                

Variable direct costs(2)

  705   160   122   987 

Adjusted fixed costs(3)

  198   83   98   379 

Other segment items(4)

  (16)  6   (2)  (12)

Total reportable segments’ adjusted EBITDA(5)

 $39  $42  $43   124 
                 

Reconciliation of total reportable segments’ adjusted EBITDA to loss from continuing operations before income taxes:

                

Interest expense, net—continuing operations

              (19)

Depreciation and amortization—continuing operations

              (69)

Corporate and other costs, net(6)

              (41)

Net income attributable to noncontrolling interests

              14 

Other adjustments:

                

Business acquisition and integration expenses and purchase accounting inventory adjustments, net

              (20)

Certain legal and other settlements and related expenses

              (1)

Amortization of pension and postretirement actuarial losses

              (8)

Restructuring, impairment and plant closing and transition costs(7)

              (14)

Loss from continuing operations before income taxes

              (34)
                 

Income tax benefit—continuing operations

              20 

Loss from discontinued operations, net of tax

              (7)

Net loss

             $(21)

 

33

 
  

March 31,

  

December 31,

 
  

2025

  

2024

 

Total assets:

        

Polyurethanes

 $4,224  $4,151 

Performance Products

  1,278   1,214 

Advanced Materials

  1,118   1,097 

Total reportable segments’ total assets

  6,620   6,462 

Corporate and other

  612   652 

Total

 $7,232  $7,114 

 

  Three months ended
  March 31,
  

2025

  

2024

 

Depreciation and amortization:

        

Polyurethanes

 $39  $37 

Performance Products

  15   17 

Advanced Materials

  13   13 

Total reportable segments’ depreciation and amortization

  67   67 

Corporate and other

  2   2 

Total

 $69  $69 

 

  Three months ended
  March 31,
  

2025

  

2024

 

Capital expenditures:

        

Polyurethanes

 $17  $15 

Performance Products

  14   22 

Advanced Materials

  4   4 

Total reportable segments’ capital expenditures

  35   41 

Corporate and other

  1   1 

Total

 $36  $42 

 


 

(1)

A reconciliation of total reportable segments’ revenues to total consolidated revenues is provided in “Note 12. Revenue Recognition.”

(2)

Variable direct costs primarily include raw materials, utilities and freight-related costs.

(3)

Adjusted fixed costs primarily include personnel and maintenance costs at our manufacturing facilities, selling, general and administrative expenses and research and development expenses, less depreciation and amortization and certain of the adjustments noted in footnote (5) below.

(4)

Other segment items include other operating and non-operating income and expense items and foreign currency exchange effects, less certain of the adjustments noted in footnote (5) below.

(5)

We use segment adjusted EBITDA as the measure of each segment’s profit or loss. We believe that segment adjusted EBITDA more accurately reflects what our chief operating decision maker, who has been determined to be our Chief Executive Officer, uses to make decisions about resources to be allocated to the segments and assess their financial performance. Segment adjusted EBITDA is defined as net income of Huntsman Corporation or Huntsman International, as appropriate, before interest, income tax, depreciation and amortization, net income attributable to noncontrolling interests and certain Corporate and other items, as well as eliminating the following adjustments: (a) business acquisition and integration gain (expenses) and purchase accounting inventory adjustments, net; (b) certain legal and other settlements and related income (expenses); (c) amortization of pension and postretirement actuarial losses; (d) restructuring, impairment, plant closing and transition costs; and (e) loss from discontinued operations, net of tax

(6)

Corporate and other costs, net includes unallocated corporate overhead, unallocated foreign exchange gains and losses, LIFO inventory valuation reserve adjustments, nonoperating income and expense and gains and losses on the disposition of corporate assets.

(7)

Includes costs associated with transition activities relating primarily to our program to realign our cost structure in Europe and our Corporate program to optimize our global approach to managed services in various information technology functions.

 

 

34

 
 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 

Results of Operations 

As discussed in “Note 4. Discontinued Operations—Sale of Textile Effects Business” to our condensed consolidated financial statements, the results from continuing operations primarily exclude the results of our Textile Effects Business for all periods presented. For each of our Company and Huntsman International, the following tables set forth the condensed consolidated results of operations (dollars in millions, except per share amounts):

Huntsman Corporation 

 

   

Three months ended

         
   

March 31,

   

Percent

 
   

2025

   

2024

   

change

 

Revenues

  $ 1,410     $ 1,470       (4 )%

Cost of goods sold

    1,209       1,269       (5 )%

Gross profit

    201       201        

Operating expenses, net

    196       209       (6 )%

Restructuring, impairment and plant closing costs

    1       11       (91 )%

Gain on acquisition of assets, net

    (5 )     (52 )     (90 )%

Prepaid asset write-off

          71       (100 )%

Income associated with litigation matter, net

    (33 )           NM  

Operating income (loss)

    42       (38 )     NM  

Interest expense, net

    (19 )     (19 )      

Equity in income of investment in unconsolidated affiliates

    1       19       (95 )%

Other income, net

    3       2       50 %

Income (loss) from continuing operations before income taxes

    27       (36 )     NM  

Income tax (expense) benefit

    (15 )     20       NM  

Income (loss) from continuing operations

    12       (16 )     NM  

Loss from discontinued operations, net of tax

    (1 )     (7 )     (86 )%

Net income (loss)

    11       (23 )     NM  

Reconciliation of net income (loss) to adjusted EBITDA(1):

                       

Net income attributable to noncontrolling interests

    (16 )     (14 )     14 %

Interest expense, net from continuing operations

    19       19        

Income tax expense (benefit) from continuing operations

    15       (20 )     NM  

Income tax benefit from discontinued operations

          (1 )     (100 )%

Depreciation and amortization from continuing operations

    69       69        

Other adjustments:

                       

Business acquisition and integration (gain) expenses and purchase accounting inventory adjustments, net

    (5 )     20          

EBITDA from discontinued operations(2)

    1       8          

Certain legal and other settlements and related (income) expenses

    (33 )     1          

Amortization of pension and postretirement actuarial losses

    7       8          

Restructuring, impairment and plant closing and transition costs(3)

    4       14          

Adjusted EBITDA(1)

  $ 72     $ 81       (11 )%
                         

Net cash used in operating activities from continuing operations

  $ (71 )   $ (63 )     13 %

Net cash provided by (used in) investing activities

    6       (30 )     NM  

Net cash provided by financing activities

    60       108       (44 )%

Capital expenditures from continuing operations

    (36 )     (42 )     (14 )%
                         

Amounts attributable to Huntsman Corporation:

                       

Loss from continuing operations

  $ (4 )   $ (30 )        

Loss from discontinued operations, net of tax

    (1 )     (7 )        

Net loss

  $ (5 )   $ (37 )        

 

35

 

Huntsman International 

 

 

   

Three months ended

         
   

March 31,

   

Percent

 
   

2025

   

2024

   

change

 

Revenues

  $ 1,410     $ 1,470       (4 )%

Cost of goods sold

    1,209       1,269       (5 )%

Gross profit

    201       201        

Operating expenses, net

    194       207       (6 )%

Restructuring, impairment and plant closing costs

    1       11       (91 )%

Gain on acquisition of assets, net

    (5 )     (52 )     (90 )%

Prepaid asset write-off

          71       (100 )%

Income associated with litigation matter, net

    (33 )           NM  

Operating income (loss)

    44       (36 )     NM  

Interest expense, net

    (19 )     (19 )      

Equity in income of investment in unconsolidated affiliates

    1       19       (95 )%

Other income, net

    3       2       50 %

Income (loss) from continuing operations before income taxes

    29       (34 )     NM  

Income tax (expense) benefit

    (17 )     20       NM  

Income (loss) from continuing operations

    12       (14 )     NM  

Loss from discontinued operations, net of tax

    (1 )     (7 )     (86 )%

Net income (loss)

    11       (21 )     NM  

Reconciliation of net income (loss) to adjusted EBITDA(1):

                       

Net income attributable to noncontrolling interests

    (16 )     (14 )     14 %

Interest expense, net from continuing operations

    19       19        

Income tax expense (benefit) from continuing operations

    17       (20 )     NM  

Income tax benefit from discontinued operations

          (1 )     (100 )%

Depreciation and amortization from continuing operations

    69       69        

Other adjustments:

                       

Business acquisition and integration (gain) expenses and purchase accounting inventory adjustments, net

    (5 )     20          

EBITDA from discontinued operations(2)

    1       8          

Certain legal and other settlements and related (income) expenses

    (33 )     1          

Amortization of pension and postretirement actuarial losses

    7       8          

Restructuring, impairment and plant closing and transition costs(3)

    4       14          

Adjusted EBITDA(1)

  $ 74     $ 83       (11 )%
                         

Net cash used in operating activities from continuing operations

  $ (70 )   $ (62 )     13 %

Net cash provided by (used in) investing activities

    1       (39 )     NM  

Net cash provided by financing activities

    64       116       (45 )%

Capital expenditures from continuing operations

    (36 )     (42 )     (14 )%
                         

Amounts attributable to Huntsman International:

                       

Loss from continuing operations

  $ (4 )   $ (28 )        

Loss from discontinued operations, net of tax

    (1 )     (7 )        

Net loss

  $ (5 )   $ (35 )        


 

36

 

Huntsman Corporation

 

   

Three months ended

   

Three months ended

 
   

March 31, 2025

   

March 31, 2024

 
           

Tax and

                   

Tax and

         
   

Gross

   

other(4)

   

Net

   

Gross

   

other(4)

   

Net

 

Reconciliation of net income (loss) to adjusted net loss(1):

                                               

Net income (loss)

                  $ 11                     $ (23 )

Net income attributable to noncontrolling interests

                    (16 )                     (14 )

Business acquisition and integration (gain) expenses and purchase accounting inventory adjustments, net

  $ (5 )   $       (5 )   $ 20     $ (18 )     2  

Loss from discontinued operations(2)

    1             1       8       (1 )     7  

Certain legal and other settlements and related (income) expenses

    (33 )     7       (26 )     1             1  

Amortization of pension and postretirement actuarial losses

    7       (2 )     5       8       (1 )     7  

Establishment of significant deferred tax asset valuation allowances

          9       9                    

Restructuring, impairment and plant closing and transition costs(3)

    4       (2 )     2       14       (5 )     9  

Adjusted net loss(1)

                  $ (19 )                   $ (11 )
                                                 

Weighted average shares-basic

                    172.4                       171.8  

Weighted average shares-diluted

                    172.4                       171.8  
                                                 

Basic net loss attributable to Huntsman Corporation per share:

                                               

Loss from continuing operations

                  $ (0.02 )                   $ (0.18 )

Loss from discontinued operations

                    (0.01 )                     (0.04 )

Net loss

                  $ (0.03 )                   $ (0.22 )
                                                 

Diluted net loss attributable to Huntsman Corporation per share:

                                               

Loss from continuing operations

                  $ (0.02 )                   $ (0.18 )

Loss from discontinued operations

                    (0.01 )                     (0.04 )

Net loss

                  $ (0.03 )                   $ (0.22 )
                                                 

Other non-GAAP measures:

                                               

Diluted adjusted net loss per share(1)

                  $ (0.11 )                   $ (0.06 )
                                                 

Net cash used in operating activities from continuing operations

                  $ (71 )                   $ (63 )

Capital expenditures from continuing operations

                    (36 )                     (42 )

Free cash flow from continuing operations(1)

                  $ (107 )                   $ (105 )
                                                 

Effective tax rate

                    56 %                     56 %

Impact of non-GAAP adjustments(5)

                    (56 )%                     1 %

Adjusted effective tax rate

                    NM                       57 %

 


NM—Not meaningful

(1)

See “—Non-GAAP Financial Measures.”

(2)

Includes the net loss on the sale of our Textile Effects Business. In addition to income tax impacts, this adjusting item is also impacted by depreciation and amortization expense and interest expense.

(3)

Includes costs associated with transition activities relating primarily to our program to realign our cost structure in Europe and our Corporate program to optimize our global approach to managed services in various information technology functions.

(4)

The income tax impacts, if any, are computed on the pre-tax adjustments using a with and without approach.

(5)

For details regarding the tax impacts of our non-GAAP adjustments, please see the reconciliation of our net income (loss) to adjusted net loss noted above.

 

 

 

37

 

Non-GAAP Financial Measures

 

Our condensed consolidated financial statements are prepared in accordance with GAAP, which we supplement with certain non-GAAP financial information. These non-GAAP measures should not be considered in isolation or as a substitute for the related GAAP measures, and other companies may define such measures differently. We encourage investors to review our financial statements and the reconciliation of the non-GAAP financial measures to the most directly comparable GAAP financial measures in their entirety and not to rely on any single financial measure. These non-GAAP measures exclude the impact of certain income and expenses that we do not believe are indicative of our core operating results.

 

Adjusted EBITDA

 

Our management uses adjusted EBITDA to assess financial performance. Adjusted EBITDA is defined as net income of Huntsman Corporation or Huntsman International, as appropriate, before interest, income tax, depreciation and amortization, net income attributable to noncontrolling interests and certain Corporate and other items, as well as eliminating the following adjustments: (a) business acquisition and integration (gain) expenses and purchase accounting inventory adjustments, net; (b) EBITDA from discontinued operations; (c) certain legal and other settlements and related (income) expenses; (d) amortization of pension and postretirement actuarial losses; and (e) restructuring, impairment and plant closing and transition costs. We believe that net income of Huntsman Corporation or Huntsman International, as appropriate, is the performance measure calculated and presented in accordance with U.S. GAAP that is most directly comparable to adjusted EBITDA.

 

We believe adjusted EBITDA is useful to investors in assessing the businesses’ ongoing financial performance and provides improved comparability between periods through the exclusion of certain items that management believes are not indicative of the businesses’ operational profitability and that may obscure underlying business results and trends. However, this measure should not be considered in isolation or viewed as a substitute for net income of Huntsman Corporation or Huntsman International, as appropriate, or other measures of performance determined in accordance with U.S. GAAP. Moreover, adjusted EBITDA as used herein is not necessarily comparable to other similarly titled measures of other companies due to potential inconsistencies in the methods of calculation. Our management believes this measure is useful to compare general operating performance from period to period and to make certain related management decisions. Adjusted EBITDA is also used by securities analysts, lenders and others in their evaluation of different companies because it excludes certain items that can vary widely across different industries or among companies within the same industry. For example, interest expense can be highly dependent on a company’s capital structure, debt levels and credit ratings. Therefore, the impact of interest expense on earnings can vary significantly among companies. In addition, the tax positions of companies can vary because of their differing abilities to take advantage of tax benefits and because of the tax policies of the various jurisdictions in which they operate. As a result, effective tax rates and tax expense can vary considerably among companies. Finally, companies employ productive assets of different ages and utilize different methods of acquiring and depreciating such assets. This can result in considerable variability in the relative costs of productive assets and the depreciation and amortization expense among companies.

 

Nevertheless, our management recognizes that there are material limitations associated with the use of adjusted EBITDA in the evaluation of our Company as compared to net income of Huntsman Corporation or Huntsman International, as appropriate, which reflects overall financial performance. For example, we have borrowed money in order to finance our operations and interest expense is a necessary element of our costs and ability to generate revenue. Our management compensates for the limitations of using adjusted EBITDA by using this measure to supplement U.S. GAAP results to provide a more complete understanding of the factors and trends affecting the business rather than U.S. GAAP results alone.

Adjusted Net Income

 

Adjusted net income is computed by eliminating the after-tax amounts related to the following from net income attributable to Huntsman Corporation: (a) business acquisition and integration (gain) expenses and purchase accounting inventory adjustments, net; (b) loss from discontinued operations; (c) certain legal and other settlements and related (income) expenses; (d) amortization of pension and postretirement actuarial losses; (e) establishment of significant deferred tax asset valuation allowances; and (f) restructuring, impairment and plant closing and transition costs. Basic adjusted net income per share excludes dilution and is computed by dividing adjusted net income by the weighted average number of shares outstanding during the period. Adjusted diluted net income per share reflects all potential dilutive common shares outstanding during the period and is computed by dividing adjusted net income by the weighted average number of shares outstanding during the period increased by the number of additional shares that would have been outstanding as dilutive securities. Adjusted net income and adjusted net income per share amounts are presented solely as supplemental information.

 

We believe adjusted net income is useful to investors in assessing the businesses’ ongoing financial performance and provides improved comparability between periods through the exclusion of certain items that management believes are not indicative of the businesses’ operational profitability and that may obscure underlying business results and trends.

 

Free Cash Flow

 

We believe free cash flow is an important indicator of our liquidity as it measures the amount of cash we generate. Management internally uses a free cash flow measure: (a) to evaluate our liquidity, (b) evaluate strategic investments, (c) plan stock buyback and dividend levels and (d) evaluate our ability to incur and service debt. 

38

 

Adjusted Effective Tax Rate

 

We believe that the effective tax rate of Huntsman Corporation or Huntsman International, as appropriate, is the performance measure calculated and presented in accordance with U.S. GAAP that is most directly comparable to adjusted effective tax rate. We believe our adjusted effective tax rate provides improved comparability between periods through the exclusion of certain items, such as, business acquisition and integration expenses and purchase accounting inventory adjustments, certain legal and other settlements and related expenses, gains on sale of businesses/assets and certain tax only items, including tax law changes not yet enacted, that we believe are not indicative of the businesses’ operational profitability and that may obscure underlying business results and trends.

 

Our forward-looking adjusted effective tax rate is calculated based on our forecast effective tax rate, and the range of our forward-looking adjusted effective tax rate equals the range of our forecast effective tax rate. We disclose forward-looking adjusted effective tax rate because we cannot adequately forecast certain items and events that may or may not impact us in the near future, such as business acquisition and integration expenses and purchase accounting inventory adjustments, certain legal and other settlements and related expenses, gains on sale of businesses/assets and certain tax only items, including tax law changes not yet enacted. Each of such adjustment has not yet occurred, is out of our control and/or cannot be reasonably predicted. In our view, our forward-looking adjusted effective tax rate represents the forecast effective tax rate on our underlying business operations but does not reflect any adjustments related to the items noted above that may occur and can cause our effective tax rate to differ.

 

Three Months Ended March 31, 2025 Compared with Three Months Ended March 31, 2024 

For the three months ended March 31, 2025, loss from continuing operations attributable to Huntsman Corporation was $4 million, an improvement of $26 million from a loss of $30 million in the 2024 period. For the three months ended March 31, 2025, loss from continuing operations attributable to Huntsman International was $4 million, an improvement of $24 million from a loss of $28 million in the 2024 period. The decreases noted above were the result of the following items:

 

 

Revenues for the three months ended March 31, 2025 decreased by $60 million, or 4%, as compared with the 2024 period. The decrease was primarily due to lower sales volumes in our Performance Products segment and lower average selling prices in our Polyurethanes and Advanced Materials segments. See “—Segment Analysis” below.

  Our operating expenses, net and the operating expenses, net of Huntsman International for the three months ended March 31, 2025 both decreased by $13 million, or 6%, as compared with the 2024 period, primarily related to decreases in selling, general and administrative expenses as well as the positive impact of translating foreign currency amounts to the U.S. dollar.

 

  Restructuring, impairment and plant closing costs for the three months ended March 31, 2025 decreased by $10 million, or 91%, as compared with the 2024 period. For more information on restructuring activities, see “Note 8. Restructuring, Impairment and Plant Closing Costs” to our condensed consolidated financial statements.

 

  Gain on acquisition of assets, net was approximately $5 million and $52 million, for three months ended March 31, 2025 and 2024, respectively, representing net gains related to the separation and acquisition of assets of SLIC. For further information, see “Note 3. Business Combinations and Acquisitions—Separation and Acquisition of Assets of SLIC Joint Venture” to our condensed consolidated financial statements.

 

  Prepaid asset write-off was approximately $71 million for the three months ended March 31, 2024. Concurrent with the acquisition of assets of SLIC, we wrote off certain prepaid assets related to operating agreements with SLIC and other joint venture partners. For further information, see “Note 3. Business Combinations and Acquisitions—Separation and Acquisition of Assets of SLIC Joint Venture” to our condensed consolidated financial statements.

 

  Income associated with litigation matter, net was approximately $33 million for the three months ended March 31, 2025. For further information, see “Note 16. Commitments and Contingencies—Legal Matters” to our condensed consolidated financial statements.

  Equity in income of investment in unconsolidated affiliates for the three months ended March 31, 2025 decreased to $1 million from $19 million in the 2024 period primarily related to a decrease in income at our PO/MTBE joint venture in China, in which we hold at 49% interest.

 

Our income tax expense for the three months ended March 31, 2025 was $15 million as compared with income tax benefit of $20 million in the 2024 period. The income tax expense of Huntsman International for the three months ended March 31, 2025 was $17 million as compared with income tax benefit of $20 million in the 2024 period. The increase in income tax expense was primarily due to our mix of income and losses in the tax jurisdictions in which we operate, as impacted by the presence of valuation allowances in certain tax jurisdictions. In particular, we recognize tax expense in jurisdictions with pre-tax income but do not recognize a tax benefit from pre-tax losses in jurisdictions with valuation allowances. In addition, during the first quarter of 2025, we recorded a discrete tax expense of $8 million resulting from income associated with the Praxair litigation and discrete establishments of valuation allowances of approximately $9 million. During the first quarter of 2024, we recorded a discrete tax benefit of $18 million resulting from the write-off of certain prepaid assets related to operating agreements with SLIC and other joint venture partners concurrent with the separation and acquisition of assets of SLIC. For further information, see “Note 19. Income Taxes” to our condensed consolidated financial statements.

39

 

Segment Analysis

 

   

Three months ended

   

Percent change

 
   

March 31,

   

(unfavorable)

 

(Dollars in millions)

 

2025

   

2024

   

favorable

 

Revenues

                       

Polyurethanes

  $ 912     $ 926       (2 )%

Performance Products

    257       291       (12 )%

Advanced Materials

    249       261       (5 )%

Total reportable segments’ revenues

    1,418       1,478       (4 )%

Intersegment eliminations

    (8 )     (8 )     NM  

Total

  $ 1,410     $ 1,470       (4 )%
                         

Huntsman Corporation

                       

Segment adjusted EBITDA(1)

                       

Polyurethanes

  $ 42     $ 39       8 %

Performance Products

    30       42       (29 )%

Advanced Materials

    36       43       (16 )%

Total reportable segments’ adjusted EBITDA

    108       124       (13 )%

Corporate and other

    (36 )     (43 )     16 %

Total

  $ 72     $ 81       (11 )%
                         

Huntsman International

                       

Segment adjusted EBITDA(1)

                       

Polyurethanes

  $ 42     $ 39       8 %

Performance Products

    30       42       (29 )%

Advanced Materials

    36       43       (16 )%

Total reportable segments’ adjusted EBITDA

    108       124       (13 )%

Corporate and other

    (34 )     (41 )     17 %

Total

  $ 74     $ 83       (11 )%

 


NM—Not meaningful

(1)

For further information, including reconciliation of total reportable segments’ adjusted EBITDA to income (loss) from continuing operations before income taxes of Huntsman Corporation or Huntsman International, as appropriate, see “Note 21. Operating Segment Information” to our condensed consolidated financial statements.

   

Three months ended March 31, 2025 vs 2024

 
   

Average selling price(1)

         
   

Local

   

Foreign currency

   

Sales

 
   

currency and mix

   

translation impact

   

volumes(2)

 

Period-over-period (decrease) increase

                       

Polyurethanes

    (3 )%     (2 )%     3 %

Performance Products

    5 %     (1 )%     (16 )%

Advanced Materials

    (4 )%     (2 )%     1 %


(1)

Excludes revenues from tolling arrangements, byproducts and raw materials.

(2)

Excludes sales volumes of byproducts and raw materials.

 

40

 

Polyurethanes

 

The decrease in revenues in our Polyurethanes segment for the three months ended March 31, 2025 compared to the same period of 2024 was primarily due to lower average selling prices, partially offset by higher sales volumes. Average selling prices decreased primarily due to unfavorable sales mix. Sales volumes increased primarily due to improved demand and share gains in certain markets. The increase in segment adjusted EBITDA was primarily due to lower raw materials costs, lower fixed costs and higher sales volumes, partially offset by unfavorable sales mix, the negative impact of major foreign currency exchange rate movements against the U.S. dollar and lower equity earnings from our minority-owned joint venture in China.

 

Performance Products

 

The decrease in revenues in our Performance Products segment for the three months ended March 31, 2025 compared to the same period of 2024 was primarily due to lower sales volumes, partially offset by favorable sales mix. Sales volumes decreased primarily due to lower customer demand and unplanned production outages at our Moers, Germany facility. The decrease in segment adjusted EBITDA was primarily due to lower sales volumes mainly in Europe, partially offset by favorable sales mix.

 

Advanced Materials

 

The decrease in revenues in our Advanced Materials segment for the three months ended March 31, 2025 compared to the same period of 2024 was primarily due to lower average selling prices. Average selling prices decreased primarily due to unfavorable sales mix and the negative impact of major foreign currency exchange rate movements against the U.S. dollar. Sales volumes remained relatively stable. The decrease in segment adjusted EBITDA was primarily due to lower average selling prices.

 

Corporate and other

Corporate and other includes unallocated corporate overhead, unallocated foreign currency exchange gains and losses, LIFO inventory valuation reserve adjustments, loss on early extinguishment of debt, unallocated restructuring, impairment and plant closing costs, nonoperating income and expense and gains and losses on the disposition of corporate assets. For the three months ended March 31, 2025, adjusted EBITDA from Corporate and other for Huntsman Corporation was a loss of $36 million as compared to a loss of $43 million for the same period of 2024. For the three months ended March 31, 2025, adjusted EBITDA from Corporate and other for Huntsman International was a loss of $34 million as compared to a loss of $41 million for the same period of 2024. The increase in adjusted EBITDA from Corporate and other resulted primarily from a decrease in corporate overhead costs and an increase in unallocated foreign currency exchange gains, partially offset by an increase in LIFO valuation losses.

 

Liquidity and Capital Resources

The following is a discussion of our liquidity and capital resources and generally does not include separate information with respect to Huntsman International in accordance with General Instructions H(1)(a) and (b) of Form 10-Q.

Cash Flows for the Three Months Ended March 31, 2025 Compared with the Three Months Ended March 31, 2024

Net cash used in operating activities from continuing operations for the three months ended March 31, 2025 and 2024 was $71 million and $63 million, respectively. The increase in net cash used in operating activities from continuing operations was primarily attributable to a net cash outflow of $59 million related to changes in operating assets and liabilities for the three months ended March 31, 2025 as compared with the same period of 2024, partially offset by an increase of $51 million in operating income from continuing operations adjusted for noncash activities as noted in our condensed consolidated statements of cash flows.

Net cash provided by (used in) investing activities for the three months ended March 31, 2025 and 2024 was $6 million and $(30) million, respectively. During the three months ended March 31, 2025 and 2024, we paid $36 million and $42 million for capital expenditures, respectively. During the three months ended March 31, 2025, we received a $41 million final liquidating distribution from SLIC. See “Note 3. Business Combinations and Acquisitions—Separation and Acquisition of Assets of SLIC Joint Venture” to our condensed consolidated financial statements. During the three months ended March 31, 2024, we received $12 million for the sale of businesses, net related to the resolution of net working capital from the sale of our Textile Effects Business. See “Note 4. Discontinued Operations—Sale of Textile Effects Business” to our condensed consolidated financial statements.

Net cash provided by financing activities for the three months ended March 31, 2025 and 2024 was $60 million and $108 million, respectively. During the three months ended March 31, 2025 and 2024, we had net borrowings from our 2022 Revolving Credit Facility and our A/R Programs of $427 million and $191 million, respectively. During the three months ended March 31, 2025, we paid approximately $315 million to satisfy and discharge our obligations under our 2025 Senior Notes. See “Note 9. Debt—Direct and Subsidiary Debt—Senior Notes” to our condensed consolidated financial statements. During the three months ended March 31, 2024, HPS paid approximately $28 million against the note payable with SLIC for the acquisition of assets. See “Note 3. Business Combinations and Acquisitions—Separation and Acquisition of Assets of SLIC Joint Venture” to our condensed consolidated financial statements.

 

​Free cash flow from continuing operations for the three months ended March 31, 2025 and 2024 was a use of cash of $107 million and $105 million, respectively. The slight decrease in free cash flow from continuing operations was primarily attributable to an increase in cash used in operating activities from continuing operations, partially offset by a decrease in cash used for capital expenditures during the three months ended March 31, 2025 as compared with the same period of 2024.

41

 

Changes in Financial Condition

The following information summarizes our working capital (dollars in millions):

   

March 31,

   

December 31,

   

(Decrease)

   

Percent

 
   

2025

   

2024

   

increase

   

change

 

Cash and cash equivalents

  $ 334     $ 340     $ (6 )     (2 )%

Accounts and notes receivable, net

    797       725       72       10 %

Inventories

    1,030       917       113       12 %

Prepaid expenses

    95       114       (19 )     (17 )%

Other current assets

    30       29       1       3 %

Total current assets

    2,286       2,125       161       8 %
                                 

Accounts payable

    738       770       (32 )     (4 )%

Accrued liabilities

    460       416       44       11 %

Current portion of debt

    284       325       (41 )     (13 )%

Current operating lease liabilities

    58       54       4       7 %

Total current liabilities

    1,540       1,565       (25 )     (2 )%

Working capital

  $ 746     $ 560     $ 186       33 %

 

​Our working capital increased by $186 million as a result of the net impact of the following significant changes:

 

The decrease in cash and cash equivalents of $6 million resulted from the matters identified on our condensed consolidated statements of cash flows. See also “—Cash Flows for the Three Months Ended March 31, 2025 Compared with the Three Months Ended March 31, 2024.”

  Accounts and notes receivable, net increased by $72 million primarily due to higher revenues in March of 2025 compared to December of 2024.

 

  Inventories increased by $113 million primarily due to higher inventory costs and volumes.

​​

  Prepaid expenses decreased by $19 million primarily due to the amortization of prepaid insurance.

 

  Accounts payable decreased by $32 million primarily due to a decrease in non-trade payables related to insurance premiums and information technology costs, partially offset by extended vendor payment terms under our supplier finance program.

 

  Accrued liabilities increased by $44 million primarily due to increases in accrued compensation, accrued taxes and accrued interest, partially offset by a decrease in accrued rebates.

 

  Current portion of debt decreased by $41 million primarily due to the satisfaction and discharge of our obligations under our 2025 Senior Notes during the first quarter of 2025, partially offset by an increase in our borrowings under our 2025 Revolving Credit Facility and our A/R Programs.

 

42

 

Liquidity

 

We depend upon our cash, our 2022 Revolving Credit Facility, our A/R Programs and other debt instruments to provide liquidity for our operations and working capital needs. As of March 31, 2025, we had $1,294 million of combined cash and unused borrowing capacity, consisting of $334 million in cash, $924 million in availability under our 2022 Revolving Credit Facility and $36 million in availability under our A/R Programs. Our liquidity can be significantly impacted by various factors. The following matters are expected to have a significant impact on our liquidity:

 

Short-Term Liquidity

 

 

During 2025, we expect to spend between approximately $180 million to $190 million on capital expenditures. Our future expenditures include certain environmental, health and safety upgrades; expansions and upgrades of our existing manufacturing and other facilities; construction of new facilities; certain cost reduction projects, including those described below; and certain information technology expenditures. We expect to fund capital expenditures with cash provided by operations. 

 

 

During the remainder of 2025, we expect to make additional contributions to our pension and other postretirement benefit plans of approximately $27 million.

 

 

As of March 31, 2025, we have approximately $547 million remaining under the authorization of our existing share repurchase program. Repurchases may be commenced or suspended from time to time without prior notice.

 

As of March 31, 2025, we had $284 million classified as current portion of debt, including $273 million outstanding under our 2022 Revolving Credit Facility, debt at our variable interest entities of $9 million and certain other short-term facilities and scheduled amortization payments totaling $2 million. We intend to renew, repay or extend the majority of these short-term facilities in the next twelve months.

 

As of March 31, 2025, we had approximately $331 million of cash and cash equivalents held by our foreign subsidiaries, including our variable interest entities. With the exception of certain amounts that we expect to repatriate in the foreseeable future, we intend to use cash held in our foreign subsidiaries to fund our local operations. Nevertheless, we could repatriate additional cash as dividends, and the repatriation of cash as a dividend would generally not be subject to U.S. taxation. However, such repatriation may potentially be subject to limited foreign withholding taxes. ​

 

For more information regarding our debt, see “Note 9. Debt” to our condensed consolidated financial statements.

 

43

 

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We are exposed to market risks, such as changes in interest rates, foreign exchange rates and commodity prices. From time to time, we enter into transactions, including transactions involving derivative instruments, to manage certain of these exposures. We also hedge our net investment in certain European operations. See “Note 10. Derivative Instruments and Hedging Activities” to our condensed consolidated financial statements.

ITEM 4. CONTROLS AND PROCEDURES

Our management, with the participation of our chief executive officer and chief financial officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of March 31, 2025. Based on this evaluation, our chief executive officer and chief financial officer have concluded that, as of March 31, 2025, our disclosure controls and procedures were effective, in that they ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is (1) recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms and (2) accumulated and communicated to our management, including our chief executive officer and chief financial officer, as appropriate to allow timely decisions regarding required disclosure.

No changes to our internal control over financial reporting occurred during the quarter ended March 31, 2025 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act). However, we can only give reasonable assurance that our internal controls over financial reporting will prevent or detect material misstatements on a timely basis.

44

 

PART II. OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS 

 

There have been no material developments with respect to the legal proceedings referenced in Part I, Item 3 of our Annual Report on Form 10-K for the year ended December 31, 2024.

 

ITEM 1A. RISK FACTORS

For information regarding risk factors, see “Part I. Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2024. 

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

The following table provides information with respect to shares of our common stock that we repurchased as part of our share repurchase program and shares of restricted stock granted under our stock incentive plans that we withheld upon vesting to satisfy our tax withholding obligations during the three months ended March 31, 2025.

                   

Total number of

   

Approximate dollar

 
                   

shares purchased

   

value of shares that

 
   

Total number

   

Average

   

as part of publicly

   

may yet be purchased

 
   

of shares

   

price paid

   

announced plans

   

under the plans or

 
   

purchased

   

per share(1)

   

or programs(2)

   

programs(2)

 

January 1 - January 31

        $           $ 547,000,000  

February 1 - February 28

    146,265       16.99             547,000,000  

March 1 - March 31

                      547,000,000  

Total

    146,265                      

(1) Represents net purchase price per share, exclusive of any fees or commissions.

(2)

On October 26, 2021, our Board of Directors approved a new share repurchase program of $1 billion. On March 25, 2022, our Board of Directors increased the authorization of our share repurchase program from $1 billion to $2 billion. The share repurchase program is supported by our free cash flow generation. Repurchases may be made in the open market, including through accelerated share repurchase programs, or in privately negotiated transactions, and repurchases may be commenced or suspended from time to time without prior notice. Shares of common stock acquired through the repurchase program are held in treasury at cost. During the three months ended March 31, 2025, we did not repurchase any shares of our common stock under this program.

45

 

ITEM 6. EXHIBITS

 

 

EXHIBIT INDEX

 

Incorporated by reference

Exhibit number

Exhibit description

Form

Exhibit

Filing date

31.1

*

Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

31.2

*

Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32.1

*

Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

32.2

*

Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101.INS

*

Inline XBRL Instance Document - The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document

101.SCH

*

Inline XBRL Taxonomy Extension Schema

101.CAL

*

Inline XBRL Taxonomy Extension Calculation Linkbase

101.LAB

*

Inline XBRL Taxonomy Extension Label Linkbase

101.PRE

*

Inline XBRL Taxonomy Extension Presentation Linkbase

101.DEF

*

Inline XBRL Taxonomy Extension Definition Linkbase

104

 

The cover page from this Quarterly Report on Form 10-Q, formatted in Inline XBRL and contained in Exhibit 101

 

*

Filed herewith

46

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrants have duly caused this report to be signed on their behalf by the undersigned thereunto duly authorized.

 

Dated: May 2, 2025

HUNTSMAN CORPORATION

HUNTSMAN INTERNATIONAL LLC

By:

/s/ PHILIP M. LISTER

Philip M. Lister

Executive Vice President and Chief Financial Officer

and Manager (Principal Financial Officer)

By:

/s/ STEVEN C. JORGENSEN

Steven C. Jorgensen

Vice President and Controller (Authorized Signatory and

Principal Accounting Officer)

47